

	Gregg H. Alton | Gilead 

































			        Gregg H. Alton
		        





Home

                /

About

                /

Senior Management

                /

                Gregg H. Alton
            














Senior Management


John F. Milligan, PhD

John C. Martin, PhD 

Gregg H. Alton

Norbert W. Bischofberger, PhD

Andrew Cheng, MD, PhD

William A. Lee, PhD

John McHutchison, MD

Jim Meyers

Brett Pletcher

Martin B. Silverstein, MD

Robin L. Washington

Katie L. Watson

Taiyin Yang, PhD

Kevin Young CBE



Board of Directors




The information in this section is intended for visitors outside the United States.
Continue










            Gregg H. Alton
        

        Executive Vice President, Corporate and Medical Affairs
    
Gregg Alton joined Gilead Sciences in 1999. From 2000 to 2009 he served as General Counsel.  In his current role, Mr. Alton is responsible for commercial and access operations in Asia, Latin America and Africa,  government affairs and policy, public affairs and medical affairs. Prior to joining Gilead, Mr. Alton was an attorney at the law firm of Cooley Godward, LLP, where he specialized in mergers and acquisitions, corporate partnerships and corporate finance transactions for healthcare and information technology companies.

Mr. Alton is a member of the boards of the AIDS Institute and the Boys and Girls Clubs of Oakland. He is also a member of the U.S. Government's Industry Trade Advisory Committee on Intellectual Property Rights, the advisory boards of UCSF Global Health Group, USC Schaeffer Center for Health Policy and Economics, Pharmozyme, Inc., the Dean’s Advisory Council at Stanford Law School and the UC Berkeley College of Letters & Science Advisory Board. In addition, he serves on Partners In Health’s Board of Trustees. Mr. Alton received a bachelor's degree in legal studies from the University of California at Berkeley, and holds a JD from Stanford University.
 




































GILD Gregg H. Alton Insider Trades for Gilead Sciences Inc.


































Bulletin






Investor Alert







Tokyo Markets Close in:



Currencies
Europe Markets
London Markets


















Expand
Keep Open
Close






Expand
Keep Open
Close






Expand
Keep Open
Close






Expand
Keep Open
Close






Expand
Keep Open
Close































Gilead Sciences Inc.

                  NASDAQ: GILD
          



GO



Set Alerts
Find a Broker




Join TD Ameritrade




Market Index


 

Overview
      
Profile
      
News
      
Charts
      
Financials
      
Historical Quotes
      
Analyst Estimates
      
Options
      
SEC Filings
      
Insiders
      


/marketstate/country/us

Gilead Sciences Inc.



After Hours
 --Quotes are delayed by 20 min
Jul 24, 2017, 7:38 p.m.


GILD

/quotes/zigman/72849/composite


$
74.38




Change

-0.01
-0.01%

Volume
Volume 1.07m
Quotes are delayed by 20 min








/quotes/zigman/72849/composite
Today's close

$
			73.76
		


$
				74.39
			
Change

+0.63
+0.85%





Day low
Day high
$73.19
$74.42










52 week low
52 week high

            $63.76
        

            $84.15
        


















Insider Activity


Individual




Gregg H. Alton



Mr. Gregg H. Alton is Secretary, EVP-Corporate & Medical Affairs at Gilead Sciences, Inc. He is on the Board of Directors at AIDS Healthcare Foundation, Gilead Foundation, Boys & Girls Club of Oakland, The Aids Institute, Inc., and Partners In Health.
Mr. Alton was previously employed as Independent Director by Celladon Corp., Independent Director by Oculus Innovative Sciences, Inc., and Attorney by Cooley Godward LLP. He also served on the board at The Bay Area Bioscience Association.
He received his undergraduate degree from the University of California, Berkeley and a graduate degree from Stanford Law School.



Transactions


Date
Shares
Transaction
Value





07/03/2017
5,000


 
Disposition at $71.06 per share.


355,300


06/01/2017
5,000


 
Disposition at $65.02 per share.


325,100


05/01/2017
5,000


 
Disposition at $68.31 per share.


341,550


03/30/2017
5,000


 
Disposition at $67.48 per share.


337,400


02/21/2017
1,430


 
Gift at $0 per share.


0


02/16/2017
6,577


 
Derivative/Non-derivative trans. at $70.31 per share.


462,429


02/16/2017
2,776


 
Award at $0 per share.


0


02/16/2017
4,940


 
Award at $0 per share.


0


02/15/2017
315


 
Award at $59.33 per share.


18,688


11/09/2016
10,000


 
Disposition at $79 per share.


790,000


09/22/2016
5,000


 
Disposition at $81.84 per share.


409,200


04/19/2016
4,126


 
Disposition at $100 per share.


412,600


04/19/2016
35,874


 
Disposition at $100.02 per share.


3,588,118


04/19/2016
35,874


 
Derivative/Non-derivative trans. at $26.99 per share.


968,239


04/01/2016
5,000


 
Disposition at $91.23 per share.


456,150


03/14/2016
5,000


 
Disposition at $90 per share.


450,000


02/16/2016
32,786


 
Derivative/Non-derivative trans. at $91.15 per share.


2,988,444


02/16/2016
42,614


 
Award at $0 per share.


0


02/16/2016
12,592


 
Award at $0 per share.


0


02/15/2016
248


 
Award at $76.02 per share.


18,852


12/01/2015
1,300


 
Disposition at $107.18 per share.


139,334


12/01/2015
4,705


 
Disposition at $106.54 per share.


501,271


12/01/2015
5,995


 
Disposition at $105.35 per share.


631,574


12/01/2015
10,000


 
Derivative/Non-derivative trans. at $24.3 per share.


243,000


11/02/2015
5,860


 
Disposition at $109.67 per share.


642,667


11/02/2015
6,140


 
Disposition at $109.1 per share.


669,874


11/02/2015
10,000


 
Derivative/Non-derivative trans. at $24.3 per share.


243,000


10/26/2015
5,000


 
Disposition at $110 per share.


550,000


10/26/2015
5,000


 
Derivative/Non-derivative trans. at $24.3 per share.


121,500


10/05/2015
5,000


 
Disposition at $100 per share.


500,000


10/05/2015
5,000


 
Derivative/Non-derivative trans. at $24.3 per share.


121,500


10/01/2015
300


 
Disposition at $98.58 per share.


29,574


10/01/2015
1,485


 
Disposition at $97.68 per share.


145,055


10/01/2015
5,215


 
Disposition at $97.09 per share.


506,325


10/01/2015
5,000


 
Derivative/Non-derivative trans. at $24.3 per share.


121,500


09/15/2015
5,000


 
Disposition at $110 per share.


550,000


09/15/2015
5,000


 
Derivative/Non-derivative trans. at $24.3 per share.


121,500


09/01/2015
600


 
Disposition at $104.11 per share.


62,466


09/01/2015
3,495


 
Disposition at $103.49 per share.


361,698


09/01/2015
7,905


 
Disposition at $102.32 per share.


808,840


09/01/2015
1,375


 
Derivative/Non-derivative trans. at $23.76 per share.


32,670


09/01/2015
8,625


 
Derivative/Non-derivative trans. at $24.3 per share.


209,587


08/03/2015
4,794


 
Disposition at $119.57 per share.


573,219


08/03/2015
12,206


 
Disposition at $118.93 per share.


1,451,660


08/03/2015
15,000


 
Derivative/Non-derivative trans. at $23.76 per share.


356,400


07/01/2015
535


 
Disposition at $117.95 per share.


63,104


07/01/2015
700


 
Disposition at $116.9 per share.


81,830


07/01/2015
765


 
Disposition at $115.91 per share.


88,672


07/01/2015
3,263


 
Disposition at $117.92 per share.


384,773


07/01/2015
4,907


 
Disposition at $117.01 per share.


574,169


07/01/2015
6,830


 
Disposition at $115.94 per share.


791,871


07/01/2015
15,000


 
Derivative/Non-derivative trans. at $23.76 per share.


356,400


06/01/2015
1,000


 
Disposition at $114.36 per share.


114,360


06/01/2015
1,000


 
Disposition at $113.35 per share.


113,350


06/01/2015
6,044


 
Disposition at $114.31 per share.


690,890


06/01/2015
8,956


 
Disposition at $113.14 per share.


1,013,282


06/01/2015
10,625


 
Derivative/Non-derivative trans. at $23.76 per share.


252,450


06/01/2015
4,375


 
Derivative/Non-derivative trans. at $23.6 per share.


103,250


05/15/2015
25,000


 
Disposition at $110.01 per share.


2,750,250


05/15/2015
625


 
Derivative/Non-derivative trans. at $23.6 per share.


14,750


05/15/2015
24,375


 
Derivative/Non-derivative trans. at $19.09 per share.


465,318


05/01/2015
1,380


 
Disposition at $106.05 per share.


146,349


05/01/2015
1,677


 
Disposition at $105.47 per share.


176,874


05/01/2015
2,240


 
Disposition at $104.34 per share.


233,722


05/01/2015
6,703


 
Disposition at $103.23 per share.


691,951


05/01/2015
10,000


 
Derivative/Non-derivative trans. at $19.09 per share.


190,900


04/08/2015
5,000


 
Disposition at $100 per share.


500,000


04/08/2015
5,000


 
Derivative/Non-derivative trans. at $19.09 per share.


95,450


04/01/2015
675


 
Disposition at $97.13 per share.


65,563


04/01/2015
1,325


 
Disposition at $96.29 per share.


127,585


04/01/2015
1,400


 
Disposition at $97.06 per share.


135,884


04/01/2015
3,600


 
Disposition at $96.3 per share.


346,680


04/01/2015
5,000


 
Derivative/Non-derivative trans. at $19.09 per share.


95,450


03/02/2015
200


 
Disposition at $104.12 per share.


20,824


03/02/2015
1,800


 
Disposition at $103.36 per share.


186,048


03/02/2015
1,393


 
Disposition at $104.21 per share.


145,165


03/02/2015
8,607


 
Disposition at $103.59 per share.


891,600


03/02/2015
10,000


 
Derivative/Non-derivative trans. at $19.09 per share.


190,900


02/17/2015
66,794


 
Derivative/Non-derivative trans. at $103.84 per share.


6,935,889


02/17/2015
85,334


 
Award at $0 per share.


0


02/17/2015
18,940


 
Award at $0 per share.


0


02/13/2015
248


 
Award at $85.61 per share.


21,231


02/02/2015
500


 
Disposition at $106.35 per share.


53,175


02/02/2015
1,500


 
Disposition at $105.27 per share.


157,905


02/02/2015
100


 
Disposition at $107.03 per share.


10,703


02/02/2015
6,270


 
Disposition at $106.07 per share.


665,059


02/02/2015
3,630


 
Disposition at $105.2 per share.


381,876


02/02/2015
10,000


 
Derivative/Non-derivative trans. at $19.09 per share.


190,900


01/08/2015
5,000


 
Disposition at $100.89 per share.


504,450


01/08/2015
5,000


 
Derivative/Non-derivative trans. at $19.09 per share.


95,450


01/02/2015
201


 
Disposition at $95.99 per share.


19,294


01/02/2015
1,799


 
Disposition at $95.06 per share.


171,013


01/02/2015
700


 
Disposition at $96.01 per share.


67,207


01/02/2015
4,300


 
Disposition at $95.04 per share.


408,672


01/02/2015
5,000


 
Derivative/Non-derivative trans. at $19.09 per share.


95,450


12/22/2014
1,000


 
Gift at $0 per share.


0


12/01/2014
600


 
Disposition at $101.45 per share.


60,870


12/01/2014
1,400


 
Disposition at $100.45 per share.


140,630


12/01/2014
10,300


 
Disposition at $101.44 per share.


1,044,832


12/01/2014
20,700


 
Disposition at $100.46 per share.


2,079,522


12/01/2014
367


 
Derivative/Non-derivative trans. at $23.76 per share.


8,719


12/01/2014
30,633


 
Derivative/Non-derivative trans. at $24.3 per share.


744,381


11/03/2014
600


 
Disposition at $112.04 per share.


67,224


11/03/2014
300


 
Disposition at $110.44 per share.


33,132


11/03/2014
1,100


 
Disposition at $109.86 per share.


120,846


11/03/2014
1,115


 
Disposition at $112.45 per share.


125,382


11/03/2014
6,877


 
Disposition at $111.89 per share.


769,468


11/03/2014
3,350


 
Disposition at $110.45 per share.


370,008


11/03/2014
19,658


 
Disposition at $109.89 per share.


2,160,218


11/03/2014
31,000


 
Derivative/Non-derivative trans. at $23.76 per share.


736,560


10/01/2014
249


 
Disposition at $106.69 per share.


26,566


10/01/2014
1,751


 
Disposition at $105.91 per share.


185,449


10/01/2014
200


 
Disposition at $107.47 per share.


21,494


10/01/2014
5,395


 
Disposition at $106.59 per share.


575,054


10/01/2014
25,405


 
Disposition at $105.83 per share.


2,688,612


10/01/2014
31,000


 
Derivative/Non-derivative trans. at $23.76 per share.


736,560


09/02/2014
767


 
Disposition at $108.98 per share.


83,588


09/02/2014
1,233


 
Disposition at $108.24 per share.


133,460


09/02/2014
13,646


 
Disposition at $109.02 per share.


1,487,687


09/02/2014
17,354


 
Disposition at $108.24 per share.


1,878,397


09/02/2014
31,000


 
Derivative/Non-derivative trans. at $23.76 per share.


736,560


08/01/2014
900


 
Disposition at $92.07 per share.


82,863


08/01/2014
1,100


 
Disposition at $91.15 per share.


100,265


08/01/2014
13,134


 
Disposition at $92.1 per share.


1,209,642


08/01/2014
17,866


 
Disposition at $91.27 per share.


1,630,630


08/01/2014
31,000


 
Derivative/Non-derivative trans. at $23.76 per share.


736,560


07/01/2014
1,300


 
Disposition at $85.04 per share.


110,552


07/01/2014
700


 
Disposition at $83.94 per share.


58,758


07/01/2014
800


 
Disposition at $85.37 per share.


68,296


07/01/2014
7,400


 
Disposition at $84.97 per share.


628,778


07/01/2014
22,800


 
Disposition at $83.76 per share.


1,909,728


07/01/2014
1,633


 
Derivative/Non-derivative trans. at $23.76 per share.


38,800


07/01/2014
29,367


 
Derivative/Non-derivative trans. at $23.6 per share.


693,061


06/02/2014
33,000


 
Disposition at $81.35 per share.


2,684,550


06/02/2014
31,000


 
Derivative/Non-derivative trans. at $23.6 per share.


731,600


05/08/2014
40,000


 
Disposition at $80 per share.


3,200,000


05/08/2014
34,633


 
Derivative/Non-derivative trans. at $23.6 per share.


817,338


05/08/2014
5,367


 
Derivative/Non-derivative trans. at $21.58 per share.


115,819


05/01/2014
1,101


 
Disposition at $79.46 per share.


87,486


05/01/2014
899


 
Disposition at $78.59 per share.


70,653


05/01/2014
6,831


 
Disposition at $79.4 per share.


542,382


05/01/2014
4,169


 
Disposition at $78.56 per share.


327,517


05/01/2014
11,000


 
Derivative/Non-derivative trans. at $21.58 per share.


237,380


04/01/2014
2,000


 
Disposition at $73.17 per share.


146,340


04/01/2014
200


 
Disposition at $73.77 per share.


14,754


04/01/2014
10,800


 
Disposition at $73.2 per share.


790,560


04/01/2014
11,000


 
Derivative/Non-derivative trans. at $21.58 per share.


237,380


03/06/2014
54,790


 
Derivative/Non-derivative trans. at $79.92 per share.


4,378,817


03/06/2014
105,000


 
Award at $0 per share.


0


03/03/2014
500


 
Disposition at $82.53 per share.


41,265


03/03/2014
1,500


 
Disposition at $81.66 per share.


122,490


03/03/2014
3,931


 
Disposition at $82.36 per share.


323,758


03/03/2014
27,069


 
Disposition at $81.76 per share.


2,213,162


03/03/2014
31,000


 
Derivative/Non-derivative trans. at $21.58 per share.


668,980


02/14/2014
968


 
Award at $21.94 per share.


21,237


02/03/2014
336


 
Disposition at $81.35 per share.


27,334


02/03/2014
1,200


 
Disposition at $80.37 per share.


96,444


02/03/2014
464


 
Disposition at $79.28 per share.


36,786


02/03/2014
22,497


 
Disposition at $81.15 per share.


1,825,632


02/03/2014
5,438


 
Disposition at $80.27 per share.


436,509


02/03/2014
3,065


 
Disposition at $79.27 per share.


242,963


02/03/2014
31,000


 
Derivative/Non-derivative trans. at $21.58 per share.


668,980


01/23/2014
11,912


 
Award at $0 per share.


0


01/23/2014
21,334


 
Award at $0 per share.


0


01/21/2014
120,000


 
Disposition at $80 per share.


9,600,000


01/21/2014
30,633


 
Derivative/Non-derivative trans. at $21.58 per share.


661,060


01/21/2014
89,367


 
Derivative/Non-derivative trans. at $19.38 per share.


1,731,932


01/02/2014
2,000


 
Disposition at $75.04 per share.


150,080


01/02/2014
1,977


 
Disposition at $75.46 per share.


149,185


01/02/2014
109,023


 
Disposition at $75.01 per share.


8,177,816


01/02/2014
10,633


 
Derivative/Non-derivative trans. at $19.38 per share.


206,067


01/02/2014
100,367


 
Derivative/Non-derivative trans. at $19.09 per share.


1,916,006


12/02/2013
200


 
Disposition at $74.72 per share.


14,944


12/02/2013
3,800


 
Disposition at $74.21 per share.


281,998


12/02/2013
774


 
Disposition at $74.74 per share.


57,849


12/02/2013
25,226


 
Disposition at $74.2 per share.


1,871,770


12/02/2013
26,000


 
Derivative/Non-derivative trans. at $19.09 per share.


496,340


11/01/2013
4,000


 
Disposition at $70.79 per share.


283,160


11/01/2013
26,000


 
Disposition at $70.79 per share.


1,840,540


11/01/2013
26,000


 
Derivative/Non-derivative trans. at $19.09 per share.


496,340


10/01/2013
4,000


 
Disposition at $62.75 per share.


251,000


10/01/2013
26,000


 
Disposition at $62.75 per share.


1,631,500


10/01/2013
11,258


 
Derivative/Non-derivative trans. at $19.09 per share.


214,915


10/01/2013
14,742


 
Derivative/Non-derivative trans. at $16.4 per share.


241,768


09/03/2013
100


 
Disposition at $61.52 per share.


6,152


09/03/2013
3,900


 
Disposition at $60.97 per share.


237,783


09/03/2013
900


 
Disposition at $61.52 per share.


55,368


09/03/2013
25,100


 
Disposition at $60.97 per share.


1,530,347


09/03/2013
26,000


 
Derivative/Non-derivative trans. at $16.4 per share.


426,400


08/30/2013
1,000


 
Gift at $0 per share.


0


08/01/2013
800


 
Disposition at $62.05 per share.


49,640


08/01/2013
29,200


 
Disposition at $61.48 per share.


1,795,216


08/01/2013
26,000


 
Derivative/Non-derivative trans. at $16.4 per share.


426,400


07/01/2013
2,400


 
Disposition at $52.66 per share.


126,384


07/01/2013
27,600


 
Disposition at $52.04 per share.


1,436,304


07/01/2013
26,000


 
Derivative/Non-derivative trans. at $16.4 per share.


426,400


06/03/2013
2,602


 
Disposition at $53.99 per share.


140,482


06/03/2013
21,698


 
Disposition at $52.8 per share.


1,145,655


06/03/2013
5,700


 
Disposition at $52.1 per share.


296,970


06/03/2013
26,000


 
Derivative/Non-derivative trans. at $16.4 per share.


426,400


05/01/2013
30,000


 
Disposition at $50.2 per share.


1,506,000


05/01/2013
26,000


 
Derivative/Non-derivative trans. at $16.4 per share.


426,400


04/01/2013
500


 
Disposition at $48.97 per share.


24,485


04/01/2013
29,500


 
Disposition at $48.36 per share.


1,426,620


04/01/2013
26,000


 
Derivative/Non-derivative trans. at $16.4 per share.


426,400


03/06/2013
14,610


 
Derivative/Non-derivative trans. at $45.4 per share.


663,294


03/06/2013
28,000


 
Award at $0 per share.


0


03/01/2013
1,100


 
Disposition at $43.43 per share.


47,773


03/01/2013
28,900


 
Disposition at $43.07 per share.


1,244,723


03/01/2013
26,000


 
Derivative/Non-derivative trans. at $16.4 per share.


426,400


02/01/2013
1,637


 
Disposition at $41.01 per share.


67,134


02/01/2013
28,363


 
Disposition at $40.38 per share.


1,145,298


02/01/2013
3,258


 
Derivative/Non-derivative trans. at $16.4 per share.


53,431


02/01/2013
22,742


 
Derivative/Non-derivative trans. at $15.47 per share.


351,818


01/30/2013
21,332


 
Award at $0 per share.


0


01/02/2013
50,000


 
Disposition at $75 per share.


3,750,000


01/02/2013
65,000


 
Disposition at $74.35 per share.


4,832,750


01/02/2013
44,371


 
Derivative/Non-derivative trans. at $29.01 per share.


1,287,202


01/02/2013
68,629


 
Derivative/Non-derivative trans. at $30.95 per share.


2,124,067


12/03/2012
2,585


 
Disposition at $75.65 per share.


195,556


12/03/2012
19,415


 
Disposition at $75.03 per share.


1,456,708


12/03/2012
21,000


 
Derivative/Non-derivative trans. at $29.01 per share.


609,210


11/01/2012
2,000


 
Disposition at $68.25 per share.


136,500


11/01/2012
20,000


 
Disposition at $67.75 per share.


1,355,000


11/01/2012
21,000


 
Derivative/Non-derivative trans. at $29.01 per share.


609,210


10/01/2012
12,000


 
Disposition at $67.93 per share.


815,160


10/01/2012
10,000


 
Disposition at $67.34 per share.


673,400


10/01/2012
21,000


 
Derivative/Non-derivative trans. at $29.01 per share.


609,210


09/04/2012
22,000


 
Disposition at $57.5 per share.


1,265,000


09/04/2012
21,000


 
Derivative/Non-derivative trans. at $29.01 per share.


609,210


08/02/2012
7,000


 
Disposition at $57.95 per share.


405,650


08/02/2012
7,000


 
Derivative/Non-derivative trans. at $19.36 per share.


135,520


08/02/2012
21,629


 
Disposition at $57.95 per share.


1,253,401


08/02/2012
21,629


 
Derivative/Non-derivative trans. at $29.01 per share.


627,457


08/02/2012
31,371


 
Disposition at $57.95 per share.


1,817,950


08/02/2012
31,371


 
Derivative/Non-derivative trans. at $21.99 per share.


689,848


08/01/2012
12,000


 
Disposition at $54.08 per share.


648,960


08/01/2012
11,000


 
Derivative/Non-derivative trans. at $21.99 per share.


241,890


07/27/2012
57,629


 
Disposition at $55.03 per share.


3,171,324


07/27/2012
57,629


 
Derivative/Non-derivative trans. at $21.99 per share.


1,267,261


07/27/2012
12,371


 
Disposition at $55.03 per share.


680,777


07/27/2012
12,371


 
Derivative/Non-derivative trans. at $19.36 per share.


239,502





        Copyright 2017 FactSet Research Systems Inc. All rights reserved. Source FactSet Fundamentals.
    











            Officers and Executives
        





Dr. John C. Martin 
Executive Chairman




Dr. John F. Milligan 
President, Chief Executive Officer & Director




Mr. Kevin B. Young 
Chief Operating Officer




Ms. Robin L. Washington 
Chief Financial Officer & Executive Vice President




Mr. Gregg H. Alton 
Executive VP-Corporate & Medical Affairs




Dr. William A. Lee 
Executive Vice President-Research




Dr. Norbert W. Bischofberger 
Chief Scientific Officer & Executive VP-Research




Dr. Andrew  Cheng 
Executive VP-Clinical Research & Development




Dr. John G. McHutchison 
Executive Vice President-Clinical Research




Dr. Alessandro  Riva 
Senior VP-Hematology & Oncology Therapeutic




Mr. Brett A. Pletcher 
Secretary, Chief Compliance Officer & Executive VP




Mr. James R. Meyers 
Executive VP-Worldwide Commercial Operations




Dr. Martin J. Silverstein 
Executive Vice President-Strategy




Dr. Taiyin  Yang 
EVP-Pharmaceutical Development & Manufacturing




Dr. George Pratt Shultz 
Director-Emeritus




Ms. Katie L. Watson 
Executive Vice President-Human Resources




Ms. Kelly A. Kramer 
Independent Director




Dr. John Francis Cogan 
Lead Independent Director




Mr. Per  Wold-Olsen 
Independent Director




Mr. Kevin E. Lofton 
Independent Director




Mr. Nicholas G. Moore 
Independent Director




Dr. Richard J. Whitley 
Independent Director




Ms. Gayle Edlund Wilson 
Independent Director









Trending Tickers


/quotes/zigman/17636479/composite VUZI+15.60%


/quotes/zigman/237947/composite JCP-5.83%


/quotes/zigman/59392505/composite NUGT-2.93%


/quotes/zigman/59386294/composite JNUG-5.94%


/quotes/zigman/65801738/composite TLT+1.11%


X




Powered by














Log In




9:55 PM EDT
July 24, 2017


/marketstate/country/us
New York

	Closed


/marketstate/country/uk
London

	Closed


/marketstate/country/jp
Tokyo

	Open





/marketstate/country/us
 


/marketstate/country/uk
 


/marketstate/country/jp
 











View All



Latest News

/news/latest
9:43pTrump jams with the Boy Scouts, but can’t decamp from politics
8:19pAlphabet earnings keep Google investors in dark
8:05pThe scientifically proven reason you should stop feeling guilty about ordering takeout
8:04pIs this why United, TSA clashed on Twitter over comic books on planes?
7:20pFed to stick to plans for rate hike, balance-sheet selloff this year
7:02pMLS says no to promotion-and-relegation regime — and $4 billion, to boot 
6:14pBitcoin platform scores key greenlight from Wall Street regulator
6:01pAlphabet falls after earnings beat: Live blog recap
5:48pIs Kushner's Statement a Turning Point for Trump Team?
5:16p30-year Treasury yield snaps six-day streak of declines
5:05pCompanies do better when CEO pay dwarfs average worker, study finds
5:04pAnadarko shares down 3% after company posts wider-than-expected loss
5:00pAlphabet falls after earnings beat: Live blog
4:55pTrump Pushes GOP for Affordable Care Act Repeal
4:52pU.S. will go single-payer route on health care: Jimmy Carter
4:45pNasdaq closes at record as tech stocks shake off broader weakness
12:56pOpinion Journal: Congress's Russia Sanctions Calculus
12:55pOpinion Journal: Robert Mueller’s Power Play
12:52pOpinion Journal: Joseph Rago 
12:38pOpinion Journal: Americans Abroad: Beware  
Loading more headlines...




dow

/quotes/zigman/627449/realtime
21,513.17

-66.90
-0.31%





nasdaq

/quotes/zigman/12633936/realtime
6,410.81

+23.05
+0.36%





s&p 500

/quotes/zigman/3870025/realtime
2,469.91

-2.63
-0.11%













Kiosk


1352872800000
1352872800000


The RetireMentors






				Retirement advice from our industry experts
				Our team of financial professionals can help you plan and save 
					for retirement, then 
				live well in it.



/conga/kiosk/retirementors.html
361307




1320411600000
1320616500000


Alerts



/conga/kiosk/alerts.html
310238




1333717800000
1333964100000


Virtual Stock Exchange





Our free stock-market game
				• Trade your virtual portfolio in real time
				• Talk strategies in group discussions
				• Find or create a game that suits you
				• Use our learning center to improve 



/conga/kiosk/games.html
310284




1245657600000
1277280000000


Location Scouts




Housing-market insights from our realty pros
																																																							Plus the latest data from Realtor.com on 21 home markets across the U.S.
• See our complete Real Estate site


/conga/kiosk/real_estate.html
357012




1404799200000
1404799200000


Lazy Portfolios





				Set it and forget it
				Check out the returns on our 8 Lazy Portfolios that are made up 
				of low-cost 
				buy-and-hold index funds.

				• How to create your own Lazy Portfolio


/conga/kiosk/lazy_portfolio.html
313134














MarketWatch.com




Site Index
Topics
Help
Feedback
Newsroom Roster

                    Media Archive
Premium Products
Mobile


Company Info
Code of Conduct
Corrections
Advertising Media Kit
Advertise Locally
Reprints & Licensing
Broker Center

                    Your Ad Choices


Follow MarketWatch


































RSS
Podcasts






WSJ.com
Barron's Online
BigCharts
Virtual Stock Exchange


Financial News London
WSJ.com Small Business
realtor.com
Mansion Global












		Copyright © 2017 MarketWatch, Inc.  All rights reserved.
		By using this site, you agree to the Terms of Service,
        Privacy Policy and Cookie Policy.
	



            Intraday Data provided by SIX Financial Information and subject to terms of use. Historical and current end-of-day data provided by SIX Financial Information. All quotes are in local exchange time. Real-time last sale data for U.S. stock quotes reflect trades reported through Nasdaq only. Intraday data delayed at least 15 minutes or per exchange requirements.
        






MarketWatch Top Stories
Link to MarketWatch's Slice.

15

























































Alton Gregg H Top Holdings  

































WhaleWisdom









Search All
Search 13F Filers Only
Search SEC Filer
Search Stocks Only
Search Mgmt Inv. Cos Only
ETFs Only
Search Active




















                      Alton Gregg H
                    

•   FOSTER CITY, CA
                      
How do I update this listing?




                                             Alton Gregg H is based out of Foster City.    WhaleWisdom has at least 33 insider transactions (Form 3,4,5) in our database for Alton Gregg H. 
                                           














Summary
13D/G
Insider (Form 4)



   Create Email Alert
 




×
Email Notification.







                   ***Log In or
                   Sign-up
                   to see more advanced email alert options such as selecting any type of
                   SEC form, multiple filers or classes of filers, and much more.***
                 

                    ...or to simply have an email sent to you whenever we receive a new
                           13F filing from Alton Gregg H, enter your
                    email address below and choose 'Submit'.
                

Your email:








Cancel














Contact Info




alton gregg h


333 LAKESIDE DRIVE

FOSTER CITY
CA
                                                        
                                                    94404


                                                      Business Phone:
                                                      6505743000
SEC SIC CODE:2836-BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)







Recent SEC Filings




4 filed on 07/06/2017
4 filed on 06/05/2017
4 filed on 05/03/2017
4 filed on 04/03/2017
4 filed on 03/02/2017
4 filed on 02/21/2017
4 filed on 02/06/2017
4 filed on 11/14/2016
4 filed on 09/26/2016
4 filed on 04/21/2016
















Schedule 13D and 13G events since 03/31/2017

Subscription required



 
Form 4 - Non-derivative Insider Transactions Since 03/31/2017
Loading...








Elevate your investments
Try it for free



























Alton Gregg H - Insider Stock Trading - OpenInsider











Sector

All Sectors

Group by Sector


Aerospace
Agriculture
Automobile
Building
Business Services
Chemical
Electrical
Energy
Fashion
Financial
Food & Beverage
Fund
Healthcare
Household
Insurance
Machinery
Media
Metals
Mining
Other
Personal Services
Real Estate
Retail
Technology
Telecom
Transportation
Utility




Industry

All Industries

Group by Industry






Insiders
Filings


All
Purchases
Sales

CIK: 1334682 - Address: Gilead Sciences, Inc., 333 Lakeside Drive, Foster City, CA 94404 200 results 

						Links
						


SECYahooGoogleFinvizTradingViewStockChartsStockTwitsDownload CSV 













TC
Stat
Stk
Ins
Fil
+d
+w
+m
+q
+h
+y
avg


S%ret111020-01410257S%wins63574739373847 




Filing Date
T Date
Ticker
IssuerInc Sector
IndIndustry
Owner
oSt
Rel
Title
T
TVal
Price
L
Qty
oc
Own
H
r2y
r1y
r6m
r3m
r6w
r3w
r7d
r3d
f1d
f1w
f1m
f3m
f6m
f1y



7/6/17 18:277/3/17GILDGilead Sciences IncDEHealthBioPrdBiological Products, (No DiagAlton Gregg HCAOEVP CommS-35571.060-5-5103D
6/5/17 18:156/1/17GILDGilead Sciences IncDEHealthBioPrdBiological Products, (No DiagAlton Gregg HCAOEVP CommS-32565.020-5-4108D
5/3/17 17:415/1/17GILDGilead Sciences IncDEHealthBioPrdBiological Products, (No DiagAlton Gregg HCAOEVP CommS-34268.3133-5-4113D-32-21-6-5144011
4/3/17 18:233/30/17GILDGilead Sciences IncDEHealthBioPrdBiological Products, (No DiagAlton Gregg HCAOEVP CommS-33767.4833-5-4118D-27-26-12-5-21010-12
11/14/16 13:0311/9/16GILDGilead Sciences IncDEHealthBioPrdBiological Products, (No DiagAlton Gregg HCAOEVP CommS-79079.0033-10-8123D-26-25-8-3-23530-2-1-11
9/26/16 16:549/22/16GILDGilead Sciences IncDEHealthBioPrdBiological Products, (No DiagAlton Gregg HCAOEVP CommS-40981.8433-5-4133D-23-19-112365-1-2-2-8-8-15
4/21/16 13:284/19/16GILDGilead Sciences IncDEHealthBioPrdBiological Products, (No DiagAlton Gregg HCAOEVP,CorpM.d96826.99333635138D42-3-2111594221-18-13-26
4/21/16 13:284/19/16GILDGilead Sciences IncDEHealthBioPrdBiological Products, (No DiagAlton Gregg HCAOEVP,CorpS.d-4,001100.0133-40-22138D42-3-2111594221-18-13-26
4/5/16 19:454/1/16GILDGilead Sciences IncDEHealthBioPrdBiological Products, (No DiagAlton Gregg HCAOEVP,CorpS-45691.2333-5-3142D30-3-3-6645220-9-11-16-28
3/15/16 19:313/14/16GILDGilead Sciences IncDEHealthBioPrdBiological Products, (No DiagAlton Gregg HCAOEVP,CorpS-45090.0033-5-3147D18-8-16-118333149-6-11-22
12/3/15 13:5712/1/15GILDGilead Sciences IncDEHealthBioPrdBiological Products, (No DiagAlton Gregg HCAOEVP,CorpM.d24324.3033108129D413-813-3-2-3-3-2-6-16-17-29
12/3/15 13:5712/1/15GILDGilead Sciences IncDEHealthBioPrdBiological Products, (No DiagAlton Gregg HCAOEVP,CorpS.d-1,272106.0133-12-8129D413-813-3-2-3-3-2-6-16-17-29
11/4/15 14:4111/2/15GILDGilead Sciences IncDEHealthBioPrdBiological Products, (No DiagAlton Gregg HCAOEVP,CorpM.d24324.3033108131D5507-83111000-7-20-21-32
11/4/15 14:4111/2/15GILDGilead Sciences IncDEHealthBioPrdBiological Products, (No DiagAlton Gregg HCAOEVP,CorpS.d-1,313109.3833-12-8131D5507-83111000-7-20-21-32
10/27/15 15:5410/26/15GILDGilead Sciences IncDEHealthBioPrdBiological Products, (No DiagAlton Gregg HCAOEVP,CorpM.d12124.303354133D57-16-4-2117721-2-17-6-30
10/27/15 15:5410/26/15GILDGilead Sciences IncDEHealthBioPrdBiological Products, (No DiagAlton Gregg HCAOEVP,CorpS.d-550110.0033-5-4133D57-16-4-2117721-2-17-6-30
10/7/15 13:2210/5/15GILDGilead Sciences IncDEHealthBioPrdBiological Products, (No DiagAlton Gregg HCAOEVP,CorpM.d12124.303354133D56-7-2-13-5-12-3-131123-1-19
10/7/15 13:2210/5/15GILDGilead Sciences IncDEHealthBioPrdBiological Products, (No DiagAlton Gregg HCAOEVP,CorpS.d-500100.0033-5-4133D56-7-2-13-5-12-3-131123-1-19
10/5/15 14:1310/1/15GILDGilead Sciences IncDEHealthBioPrdBiological Products, (No DiagAlton Gregg HCAOEVP,CorpM.d12124.303354133D59-51-15-6-10-7212120-2-19
10/5/15 14:1310/1/15GILDGilead Sciences IncDEHealthBioPrdBiological Products, (No DiagAlton Gregg HCAOEVP,CorpS.d-68197.2833-7-5133D59-51-15-6-10-7212120-2-19
9/17/15 15:559/15/15GILDGilead Sciences IncDEHealthBioPrdBiological Products, (No DiagAlton Gregg HCAOEVP,CorpM.d12124.303354135D78712-6-64921-5-8-8-19-28
9/17/15 15:559/15/15GILDGilead Sciences IncDEHealthBioPrdBiological Products, (No DiagAlton Gregg HCAOEVP,CorpS.d-550110.0033-5-4135D78712-6-64921-5-8-8-19-28
9/3/15 15:069/1/15GILDGilead Sciences IncDEHealthBioPrdBiological Products, (No DiagAlton Gregg HCAOEVP,CorpM.d24224.2233108135D72-41-8-11-94-3-23-51-16-24
9/3/15 15:069/1/15GILDGilead Sciences IncDEHealthBioPrdBiological Products, (No DiagAlton Gregg HCAOEVP,CorpS.d-1,233102.7533-12-8135D72-41-8-11-94-3-23-51-16-24
8/4/15 17:088/3/15GILDGilead Sciences IncDEHealthBioPrdBiological Products, (No DiagAlton Gregg HCAOEVP,CorpM.d35623.76331512137D94311314-22230-2-15-9-30-32
8/4/15 17:088/3/15GILDGilead Sciences IncDEHealthBioPrdBiological Products, (No DiagAlton Gregg HCAOEVP,CorpS.d-2,025119.1133-17-11137D94311314-22230-2-15-9-30-32
7/6/15 16:017/1/15GILDGilead Sciences IncDEHealthBioPrdBiological Products, (No DiagAlton Gregg HCAOEVP,CorpM.d35623.76331512139D1213322174-2-600-23-15-12-25
7/6/15 16:017/1/15GILDGilead Sciences IncDEHealthBioPrdBiological Products, (No DiagAlton Gregg HCAOEVP,CorpS.d-1,984116.7333-17-11139D1213322174-2-600-23-15-12-25
6/3/15 18:076/1/15GILDGilead Sciences IncDEHealthBioPrdBiological Products, (No DiagAlton Gregg HCAOEVP,CorpM.d35623.71331512141D1094014118821-102-8-7-23
6/3/15 18:076/1/15GILDGilead Sciences IncDEHealthBioPrdBiological Products, (No DiagAlton Gregg HCAOEVP,CorpS.d-1,932113.6433-17-11141D1094014118821-102-8-7-23
5/19/15 19:255/15/15GILDGilead Sciences IncDEHealthBioPrdBiological Products, (No DiagAlton Gregg HCAOEVP,CorpM.d48019.20332521143D1023777127940-186-6-24
5/19/15 19:255/15/15GILDGilead Sciences IncDEHealthBioPrdBiological Products, (No DiagAlton Gregg HCAOEVP,CorpS.d-2,750110.0133-25-15143D1023777127940-186-6-24
5/5/15 19:385/1/15GILDGilead Sciences IncDEHealthBioPrdBiological Products, (No DiagAlton Gregg HCAOEVP,CorpM.d19119.0933107143D10236-705303-1211166-14
5/5/15 19:385/1/15GILDGilead Sciences IncDEHealthBioPrdBiological Products, (No DiagAlton Gregg HCAOEVP,CorpS.d-1,249104.0733-12-8143D10236-705303-1211166-14
4/9/15 16:404/8/15GILDGilead Sciences IncDEHealthBioPrdBiological Products, (No DiagAlton Gregg HCAOEVP,CorpM.d9519.093354145D11238-52-40-1113112-3-4
4/9/15 16:404/8/15GILDGilead Sciences IncDEHealthBioPrdBiological Products, (No DiagAlton Gregg HCAOEVP,CorpS.d-500100.0033-5-3145D11238-52-40-1113112-3-4
4/3/15 17:244/1/15GILDGilead Sciences IncDEHealthBioPrdBiological Products, (No DiagAlton Gregg HCAOEVP,CorpM.d9519.093354145D10733-74-4-1-3-2148181-2
4/3/15 17:244/1/15GILDGilead Sciences IncDEHealthBioPrdBiological Products, (No DiagAlton Gregg HCAOEVP,CorpS.d-67696.5333-7-5145D10733-74-4-1-3-2148181-2
3/4/15 19:493/2/15GILDGilead Sciences IncDEHealthBioPrdBiological Products, (No DiagAlton Gregg HCAOEVP,CorpM.d19119.0933107147D13726-42-150-10-4-5112-13
3/4/15 19:493/2/15GILDGilead Sciences IncDEHealthBioPrdBiological Products, (No DiagAlton Gregg HCAOEVP,CorpS.d-1,244103.6433-12-8147D13726-42-150-10-4-5112-13
2/4/15 20:512/2/15GILDGilead Sciences IncDEHealthBioPrdBiological Products, (No DiagAlton Gregg HCAOEVP,CorpM.d19119.09331010112D1643616-4-11023205420-10
2/4/15 20:512/2/15GILDGilead Sciences IncDEHealthBioPrdBiological Products, (No DiagAlton Gregg HCAOEVP,CorpS.d-1,269105.7333-12-10112D1643616-4-11023205420-10
1/12/15 15:061/8/15GILDGilead Sciences IncDEHealthBioPrdBiological Products, (No DiagAlton Gregg HCAOEVP,CorpM.d9519.093355114D1633815-32-375-1-1-4012-4
1/12/15 15:061/8/15GILDGilead Sciences IncDEHealthBioPrdBiological Products, (No DiagAlton Gregg HCAOEVP,CorpS.d-504100.8933-5-4114D1633815-32-375-1-1-4012-4
1/6/15 16:201/2/15GILDGilead Sciences IncDEHealthBioPrdBiological Products, (No DiagAlton Gregg HCAOEVP,CorpM.d9519.093355114D1583011-9-4-7822411183
1/6/15 16:201/2/15GILDGilead Sciences IncDEHealthBioPrdBiological Products, (No DiagAlton Gregg HCAOEVP,CorpS.d-66695.1733-7-6114D1583011-9-4-7822411183
12/3/14 19:1312/1/14GILDGilead Sciences IncDEHealthBioPrdBiological Products, (No DiagAlton Gregg HCAOEVP,CorpM.d75324.29333136117D1733723-7-4-52215-62134
12/3/14 19:1312/1/14GILDGilead Sciences IncDEHealthBioPrdBiological Products, (No DiagAlton Gregg HCAOEVP,CorpS.d-3,326100.7933-33-22117D1733723-7-4-52215-62134
11/5/14 20:0611/3/14GILDGilead Sciences IncDEHealthBioPrdBiological Products, (No DiagAlton Gregg HCAOEVP,CorpM.d73623.76333135119D227583918114-1-412-4-6-43
11/5/14 20:0611/3/14GILDGilead Sciences IncDEHealthBioPrdBiological Products, (No DiagAlton Gregg HCAOEVP,CorpS.d-3,646110.5033-33-22119D227583918114-1-412-4-6-43
10/3/14 14:5310/1/14GILDGilead Sciences IncDEHealthBioPrdBiological Products, (No DiagAlton Gregg HCAOEVP,CorpM.d73623.76333135121D21568411921-1-3217-9-6-5
10/3/14 14:5310/1/14GILDGilead Sciences IncDEHealthBioPrdBiological Products, (No DiagAlton Gregg HCAOEVP,CorpS.d-3,497105.9833-33-21121D21568411921-1-3217-9-6-5
9/4/14 17:099/2/14GILDGilead Sciences IncDEHealthBioPrdBiological Products, (No DiagAlton Gregg HCAOEVP,CorpM.d73623.76333134123D279803232211652-11-2-4-3-2
9/4/14 17:099/2/14GILDGilead Sciences IncDEHealthBioPrdBiological Products, (No DiagAlton Gregg HCAOEVP,CorpS.d-3,583108.5833-33-21123D279803232211652-11-2-4-3-2
8/5/14 13:358/1/14GILDGilead Sciences IncDEHealthBioPrdBiological Products, (No DiagAlton Gregg HCAOEVP,CorpM.d73623.76333133125D2394917151442-20119221629
8/5/14 13:358/1/14GILDGilead Sciences IncDEHealthBioPrdBiological Products, (No DiagAlton Gregg HCAOEVP,CorpS.d-3,02391.6233-33-21125D2394917151442-20119221629
7/3/14 15:147/1/14GILDGilead Sciences IncDEHealthBioPrdBiological Products, (No DiagAlton Gregg HCAOEVP,CorpM.d73223.61333132127D248671618688512521833
7/3/14 15:147/1/14GILDGilead Sciences IncDEHealthBioPrdBiological Products, (No DiagAlton Gregg HCAOEVP,CorpS.d-2,77684.1233-33-21127D248671618688512521833
6/4/14 17:216/2/14GILDGilead Sciences IncDEHealthBioPrdBiological Products, (No DiagAlton Gregg HCAOEVP,CorpM.d73223.60333132129D22755100133010-45322138
6/4/14 17:216/2/14GILDGilead Sciences IncDEHealthBioPrdBiological Products, (No DiagAlton Gregg HCAOEVP,CorpS.d-2,68581.3533-33-20129D22755100133010-45322138
5/12/14 15:385/8/14GILDGilead Sciences IncDEHealthBioPrdBiological Products, (No DiagAlton Gregg HCAOEVP,CorpM.d93323.33334044131D22051181161122110163431
5/12/14 15:385/8/14GILDGilead Sciences IncDEHealthBioPrdBiological Products, (No DiagAlton Gregg HCAOEVP,CorpS.d-3,20080.0033-40-23131D22051181161122110163431
5/5/14 17:235/1/14GILDGilead Sciences IncDEHealthBioPrdBiological Products, (No DiagAlton Gregg HCAOEVP,CorpM.d23721.5833119131D199497-481852-203154433
5/5/14 17:235/1/14GILDGilead Sciences IncDEHealthBioPrdBiological Products, (No DiagAlton Gregg HCAOEVP,CorpS.d-1,02879.0833-13-9131D199497-481852-203154433
4/3/14 15:204/1/14GILDGilead Sciences IncDEHealthBioPrdBiological Products, (No DiagAlton Gregg HCAOEVP,CorpM.d23721.5833119133D2105518-2-11-5380-45184333
4/3/14 15:204/1/14GILDGilead Sciences IncDEHealthBioPrdBiological Products, (No DiagAlton Gregg HCAOEVP,CorpS.d-95273.2033-13-9133D2105518-2-11-5380-45184333
3/5/14 14:503/3/14GILDGilead Sciences IncDEHealthBioPrdBiological Products, (No DiagAlton Gregg HCAOEVP,CorpM.d66921.5833315884D264893811210-10-4-1103224
3/5/14 14:503/3/14GILDGilead Sciences IncDEHealthBioPrdBiological Products, (No DiagAlton Gregg HCAOEVP,CorpS.d-2,70181.8433-33-2884D264893811210-10-4-1103224
2/5/14 18:342/3/14GILDGilead Sciences IncDEHealthBioPrdBiological Products, (No DiagAlton Gregg HCAOEVP,CorpM.d66921.5833315786D234107351610921-24201725
2/5/14 18:342/3/14GILDGilead Sciences IncDEHealthBioPrdBiological Products, (No DiagAlton Gregg HCAOEVP,CorpS.d-2,66680.7833-33-2886D234107351610921-24201725
1/22/14 19:151/21/14GILDGilead Sciences IncDEHealthBioPrdBiological Products, (No DiagAlton Gregg HCAOEVP,CorpM.d2,39219.943312033D24310837201091080-21-11926
1/22/14 19:151/21/14GILDGilead Sciences IncDEHealthBioPrdBiological Products, (No DiagAlton Gregg HCAOEVP,CorpS.d-9,60080.0033-120-7833D24310837201091080-21-11926
1/6/14 17:391/2/14GILDGilead Sciences IncDEHealthBioPrdBiological Products, (No DiagAlton Gregg HCAOEVP,CorpM.d2,12219.113311133D26398392056-1-1-1212-11932
1/6/14 17:391/2/14GILDGilead Sciences IncDEHealthBioPrdBiological Products, (No DiagAlton Gregg HCAOEVP,CorpS.d-8,47775.0133-113-7733D26398392056-1-1-1212-11932
12/4/13 15:5212/2/13GILDGilead Sciences IncDEHealthBioPrdBiological Products, (No DiagAlton Gregg HCAOEVP,CorpM.d49619.09332629135D263944419671-3013101439
12/4/13 15:5212/2/13GILDGilead Sciences IncDEHealthBioPrdBiological Products, (No DiagAlton Gregg HCAOEVP,CorpS.d-2,22774.2233-30-4635D263944419671-3013101439
11/5/13 19:5811/1/13GILDGilead Sciences IncDEHealthBioPrdBiological Products, (No DiagAlton Gregg HCAOEVP,CorpM.d49619.09332620139D2381073116119-1-5-3-34121358
11/5/13 19:5811/1/13GILDGilead Sciences IncDEHealthBioPrdBiological Products, (No DiagAlton Gregg HCAOEVP,CorpS.d-2,12470.7933-30-4439D2381073116119-1-5-3-34121358
10/3/13 16:1110/1/13GILDGilead Sciences IncDEHealthBioPrdBiological Products, (No DiagAlton Gregg HCAOEVP,CorpM.d45717.56332615443D2188831206-10-22-515222069
10/3/13 16:1110/1/13GILDGilead Sciences IncDEHealthBioPrdBiological Products, (No DiagAlton Gregg HCAOEVP,CorpS.d-1,88362.7533-30-4143D2188831206-10-22-515222069
9/5/13 19:439/3/13GILDGilead Sciences IncDEHealthBioPrdBiological Products, (No DiagAlton Gregg HCAOEVP,CorpM.d42616.40332612447D20611335222520031193175
9/5/13 19:439/3/13GILDGilead Sciences IncDEHealthBioPrdBiological Products, (No DiagAlton Gregg HCAOEVP,CorpS.d-1,83060.9933-30-3947D20611335222520031193175
8/5/13 16:098/1/13GILDGilead Sciences IncDEHealthBioPrdBiological Products, (No DiagAlton Gregg HCAOEVP,CorpM.d42616.40332610052D197127521226730-2-30172951
8/5/13 16:098/1/13GILDGilead Sciences IncDEHealthBioPrdBiological Products, (No DiagAlton Gregg HCAOEVP,CorpS.d-1,84561.4933-30-3752D197127521226730-2-30172951
7/3/13 17:387/1/13GILDGilead Sciences IncDEHealthBioPrdBiological Products, (No DiagAlton Gregg HCAOEVP,CorpM.d42616.4033268756D1521094210-82723619214467
7/3/13 17:387/1/13GILDGilead Sciences IncDEHealthBioPrdBiological Products, (No DiagAlton Gregg HCAOEVP,CorpS.d-1,56352.0933-30-3556D1521094210-82723619214467
6/5/13 17:266/3/13GILDGilead Sciences IncDEHealthBioPrdBiological Products, (No DiagAlton Gregg HCAOEVP,CorpM.d42616.4033267760D1531094016-2-7-6-6244214763
6/5/13 17:266/3/13GILDGilead Sciences IncDEHealthBioPrdBiological Products, (No DiagAlton Gregg HCAOEVP,CorpS.d-1,58352.7733-30-3360D1531094016-2-7-6-6244214763
5/3/13 17:125/1/13GILDGilead Sciences IncDEHealthBioPrdBiological Products, (No DiagAlton Gregg HCAOEVP,CorpM.d42616.4033266964D1691015632170-22-1-4-4133443
5/3/13 17:125/1/13GILDGilead Sciences IncDEHealthBioPrdBiological Products, (No DiagAlton Gregg HCAOEVP,CorpS.d-1,50650.2033-30-3264D1691015632170-22-1-4-4133443
4/3/13 18:164/1/13GILDGilead Sciences IncDEHealthBioPrdBiological Products, (No DiagAlton Gregg HCAOEVP,CorpM.d42616.4033266268D12910346331448101583254
4/3/13 18:164/1/13GILDGilead Sciences IncDEHealthBioPrdBiological Products, (No DiagAlton Gregg HCAOEVP,CorpS.d-1,45148.3733-30-3168D12910346331448101583254
3/5/13 16:073/1/13GILDGilead Sciences IncDEHealthBioPrdBiological Products, (No DiagAlton Gregg HCAOEVP,CorpM.d42616.4033268059D12893521712962126183586
3/5/13 16:073/1/13GILDGilead Sciences IncDEHealthBioPrdBiological Products, (No DiagAlton Gregg HCAOEVP,CorpS.d-1,29243.0833-30-3459D12893521712962126183586
2/5/13 16:492/1/13GILDGilead Sciences IncDEHealthBioPrdBiological Products, (No DiagAlton Gregg HCAOEVP,CorpM.d40515.5933267362D106614817721-1-20123552105
2/5/13 16:492/1/13GILDGilead Sciences IncDEHealthBioPrdBiological Products, (No DiagAlton Gregg HCAOEVP,CorpS.d-1,21340.4233-30-3362D106614817721-1-20123552105
1/4/13 15:491/2/13GILDGilead Sciences IncDEHealthBioPrdBiological Products, (No DiagAlton Gregg HCAOEVP,CorpM.d3,41130.183311333D107834511-1-234146264298
1/4/13 15:491/2/13GILDGilead Sciences IncDEHealthBioPrdBiological Products, (No DiagAlton Gregg HCAOEVP,CorpS.d-8,58374.6333-115-7833D107834511-1-234146264298
12/5/12 18:3012/3/12GILDGilead Sciences IncDEHealthBioPrdBiological Products, (No DiagAlton Gregg HCAOEVP,CorpM.d60929.01332115235D97875129112-3-2-122213895
12/5/12 18:3012/3/12GILDGilead Sciences IncDEHealthBioPrdBiological Products, (No DiagAlton Gregg HCAOEVP,CorpS.d-1,65275.1033-22-3935D97875129112-3-2-122213895
11/5/12 20:2511/1/12GILDGilead Sciences IncDEHealthBioPrdBiological Products, (No DiagAlton Gregg HCAOEVP,CorpM.d60929.01332114236D666330170-1101-3112159107
11/5/12 20:2511/1/12GILDGilead Sciences IncDEHealthBioPrdBiological Products, (No DiagAlton Gregg HCAOEVP,CorpS.d-1,49267.8033-22-3836D666330170-1101-3112159107
10/3/12 12:4610/1/12GILDGilead Sciences IncDEHealthBioPrdBiological Products, (No DiagAlton Gregg HCAOEVP,CorpM.d60929.01332113337D968344332216241-1-393682
10/3/12 12:4610/1/12GILDGilead Sciences IncDEHealthBioPrdBiological Products, (No DiagAlton Gregg HCAOEVP,CorpS.d-1,48967.6633-22-3737D968344332216241-1-393682
9/6/12 18:409/4/12GILDGilead Sciences IncDEHealthBioPrdBiological Products, (No DiagAlton Gregg HCAOEVP,CorpM.d60929.01332112538D765128191412200172555113
9/6/12 18:409/4/12GILDGilead Sciences IncDEHealthBioPrdBiological Products, (No DiagAlton Gregg HCAOEVP,CorpS.d-1,26557.5033-22-3738D765128191412200172555113
8/3/12 18:018/1/12GILDGilead Sciences IncDEHealthBioPrdBiological Products, (No DiagAlton Gregg HCAOEVP,CorpM.dm1,69423.86337139D6344161115121231011842110
8/3/12 18:018/1/12GILDGilead Sciences IncDEHealthBioPrdBiological Products, (No DiagAlton Gregg HCAOEVP,CorpS.dm-4,12657.3033-72-6539D6344161115121231011842110
7/31/12 13:467/27/12GILDGilead Sciences IncDEHealthBioPrdBiological Products, (No DiagAlton Gregg HCAOEVP,CorpM.d1,50621.52337040D673114711839-2442142123
7/31/12 13:467/27/12GILDGilead Sciences IncDEHealthBioPrdBiological Products, (No DiagAlton Gregg HCAOEVP,CorpS.d-3,85255.0333-70-6440D673114711839-2442142123
7/3/12 19:017/2/12GILDGilead Sciences IncDEHealthBioPrdBiological Products, (No DiagAlton Gregg HCAOEVP,CorpM.dm29019.3633156140D48232661431-1-133044106
7/3/12 19:017/2/12GILDGilead Sciences IncDEHealthBioPrdBiological Products, (No DiagAlton Gregg HCAOEVP,CorpS.dm-82651.6333-16-2940D48232661431-1-133044106
6/5/12 13:276/1/12GILDGilead Sciences IncDEHealthBioPrdBiological Products, (No DiagAlton Gregg HCAOEVP,CorpM.d13619.363372140D4220246-4-6-2-3-1161751109
6/5/12 13:276/1/12GILDGilead Sciences IncDEHealthBioPrdBiological Products, (No DiagAlton Gregg HCAOEVP,CorpS.d-39249.0333-8-1740D4220246-4-6-2-3-1161751109
5/3/12 18:325/1/12GILDGilead Sciences IncDEHealthBioPrdBiological Products, (No DiagAlton Gregg HCAOEVP,CorpM.dm21319.3633113741D352525612131-1-2-1-5431111
5/3/12 18:325/1/12GILDGilead Sciences IncDEHealthBioPrdBiological Products, (No DiagAlton Gregg HCAOEVP,CorpS.dm-62251.7933-12-2341D352525612131-1-2-1-5431111
4/23/12 19:434/19/12GILDGilead Sciences IncDEHealthBioPrdBiological Products, (No DiagAlton Gregg HCAOEVP,CorpM.d1,38417.75337842D262525811412921-133397
4/23/12 19:434/19/12GILDGilead Sciences IncDEHealthBioPrdBiological Products, (No DiagAlton Gregg HCAOEVP,CorpS.d-4,21053.9833-78-6542D262525811412921-133397
4/4/12 13:444/2/12GILDGilead Sciences IncDEHealthBioPrdBiological Products, (No DiagAlton Gregg HCAOEVP,CorpM.d7017.503341142D61227158331-2-6784496
4/4/12 13:444/2/12GILDGilead Sciences IncDEHealthBioPrdBiological Products, (No DiagAlton Gregg HCAOEVP,CorpS.d-24348.5333-5-1142D61227158331-2-6784496
3/19/12 20:133/15/12GILDGilead Sciences IncDEHealthBioPrdBiological Products, (No DiagAlton Gregg HCAOEVP,CorpM.d10517.503361643D-1161721-1533000-173290
3/19/12 20:133/15/12GILDGilead Sciences IncDEHealthBioPrdBiological Products, (No DiagAlton Gregg HCAOEVP,CorpS.d-28247.0033-6-1243D-1161721-1533000-173290
3/12/12 17:353/8/12GILDGilead Sciences IncDEHealthBioPrdBiological Products, (No DiagAlton Gregg HCAOEVP,CorpM.d10517.503362135D-2121717-5-21011-182899
3/12/12 17:353/8/12GILDGilead Sciences IncDEHealthBioPrdBiological Products, (No DiagAlton Gregg HCAOEVP,CorpS.d-41746.3533-9-2135D-2121717-5-21011-182899
12/5/11 20:1312/1/11GILDGilead Sciences IncDEHealthBioPrdBiological Products, (No DiagAlton Gregg HCAOEVP,CorpM.d12217.503372338D-156-41-5-420-1-35152187
12/5/11 20:1312/1/11GILDGilead Sciences IncDEHealthBioPrdBiological Products, (No DiagAlton Gregg HCAOEVP,CorpS.d-31939.8433-8-1738D-156-41-5-420-1-35152187
11/3/11 16:1711/1/11GILDGilead Sciences IncDEHealthBioPrdBiological Products, (No DiagAlton Gregg HCAOEVP,CorpM.d29317.2533177839D-6311071-2-4-1-3-4342364
11/3/11 16:1711/1/11GILDGilead Sciences IncDEHealthBioPrdBiological Products, (No DiagAlton Gregg HCAOEVP,CorpS.d-32841.0133-8-1739D-6311071-2-4-1-3-4342364
10/26/11 17:4610/24/11GILDGilead Sciences IncDEHealthBioPrdBiological Products, (No DiagAlton Gregg HCAOEVP,CorpM.d16016.0133105130D-543-445201-1-5172765
10/26/11 17:4610/24/11GILDGilead Sciences IncDEHealthBioPrdBiological Products, (No DiagAlton Gregg HCAOEVP,CorpS.d-42042.0033-10-2530D-543-445201-1-5172765
10/5/11 20:3510/3/11GILDGilead Sciences IncDEHealthBioPrdBiological Products, (No DiagAlton Gregg HCAOEVP,CorpM.d11216.013373130D-165-9-10-3-4-1-311582181
10/5/11 20:3510/3/11GILDGilead Sciences IncDEHealthBioPrdBiological Products, (No DiagAlton Gregg HCAOEVP,CorpS.d-30738.4433-8-2130D-165-9-10-3-4-1-311582181
9/6/11 19:519/1/11GILDGilead Sciences IncDEHealthBioPrdBiological Products, (No DiagAlton Gregg HCAOEVP,CorpM.d11216.013372931D-1514-5-5-942-33-2-221950
9/6/11 19:519/1/11GILDGilead Sciences IncDEHealthBioPrdBiological Products, (No DiagAlton Gregg HCAOEVP,CorpS.d-31939.8733-8-2131D-1514-5-5-942-33-2-221950
8/3/11 18:268/1/11GILDGilead Sciences IncDEHealthBioPrdBiological Products, (No DiagAlton Gregg HCAOEVP,CorpM.d19216.0133126132D-18175-31-3-6-6-6-4052334
8/3/11 18:268/1/11GILDGilead Sciences IncDEHealthBioPrdBiological Products, (No DiagAlton Gregg HCAOEVP,CorpS.d-54341.7533-13-2932D-18175-31-3-6-6-6-4052334
7/8/11 20:217/6/11GILDGilead Sciences IncDEHealthBioPrdBiological Products, (No DiagAlton Gregg HCAOEVP,CorpM.d24016.0133158732D-5231425862-3-3-11-8020
7/8/11 20:217/6/11GILDGilead Sciences IncDEHealthBioPrdBiological Products, (No DiagAlton Gregg HCAOEVP,CorpS.d-63042.0033-15-3232D-5231425862-3-3-11-8020
7/6/11 18:487/1/11GILDGilead Sciences IncDEHealthBioPrdBiological Products, (No DiagAlton Gregg HCAOEVP,CorpM.d11216.013372832D-92014-335401-2-6-11-124
7/6/11 18:487/1/11GILDGilead Sciences IncDEHealthBioPrdBiological Products, (No DiagAlton Gregg HCAOEVP,CorpS.d-33441.7133-8-2032D-92014-335401-2-6-11-124
6/3/11 19:346/1/11GILDGilead Sciences IncDEHealthBioPrdBiological Products, (No DiagAlton Gregg HCAOEVP,CorpM.d11216.013372732D-7151142021002-3-318
6/3/11 19:346/1/11GILDGilead Sciences IncDEHealthBioPrdBiological Products, (No DiagAlton Gregg HCAOEVP,CorpS.d-33241.5233-8-2032D-7151142021002-3-318
5/3/11 19:185/2/11GILDGilead Sciences IncDEHealthBioPrdBiological Products, (No DiagAlton Gregg HCAOEVP,CorpM.d11216.013372633D-92361-102-1-1-10324
5/3/11 19:185/2/11GILDGilead Sciences IncDEHealthBioPrdBiological Products, (No DiagAlton Gregg HCAOEVP,CorpS.d-32040.0633-8-1933D-92361-102-1-1-10324
4/5/11 21:154/1/11GILDGilead Sciences IncDEHealthBioPrdBiological Products, (No DiagAlton Gregg HCAOEVP,CorpM.d19216.0133125334D-9-62117118210-1-1-1-915
4/5/11 21:154/1/11GILDGilead Sciences IncDEHealthBioPrdBiological Products, (No DiagAlton Gregg HCAOEVP,CorpS.d-55242.4733-13-2734D-9-62117118210-1-1-1-915
3/28/11 20:423/24/11GILDGilead Sciences IncDEHealthBioPrdBiological Products, (No DiagAlton Gregg HCAOEVP,CorpM.d46415.45333065435D-4-715161026412-5-5-813
3/28/11 20:423/24/11GILDGilead Sciences IncDEHealthBioPrdBiological Products, (No DiagAlton Gregg HCAOEVP,CorpS.d-1,26042.0033-30-4635D-4-715161026412-5-5-813
3/3/11 19:053/1/11GILDGilead Sciences IncDEHealthBioPrdBiological Products, (No DiagAlton Gregg HCAOEVP,CorpM.d10715.273373030D-13-1823722-102463017
3/3/11 19:053/1/11GILDGilead Sciences IncDEHealthBioPrdBiological Products, (No DiagAlton Gregg HCAOEVP,CorpS.d-31138.9333-8-2130D-13-1823722-102463017
2/3/11 19:442/1/11GILDGilead Sciences IncDEHealthBioPrdBiological Products, (No DiagAlton Gregg HCAOEVP,CorpM.dm10715.273372931D-25-1712-284330-157327
2/3/11 19:442/1/11GILDGilead Sciences IncDEHealthBioPrdBiological Products, (No DiagAlton Gregg HCAOEVP,CorpS.dm-30938.5933-8-2031D-25-1712-284330-157327
1/28/11 21:311/26/11GILDGilead Sciences IncDEHealthBioPrdBiological Products, (No DiagAlton Gregg HCAOEVP,CorpM.d4615.273331032D-23-1817-1441201231327
1/28/11 21:311/26/11GILDGilead Sciences IncDEHealthBioPrdBiological Products, (No DiagAlton Gregg HCAOEVP,CorpS.d-11739.0033-3-932D-23-1817-1441201231327
1/5/11 20:041/3/11GILDGilead Sciences IncDEHealthBioPrdBiological Products, (No DiagAlton Gregg HCAOEVP,CorpM.d8415.273362132D-27-1463-2-1220-13121312
1/5/11 20:041/3/11GILDGilead Sciences IncDEHealthBioPrdBiological Products, (No DiagAlton Gregg HCAOEVP,CorpS.d-24036.9133-7-1732D-27-1463-2-1220-13121312
12/3/10 20:4812/1/10GILDGilead Sciences IncDEHealthBioPrdBiological Products, (No DiagAlton Gregg HCAOEVP,CorpM.d8415.273362033D-14-19914-4-302-1-1-29106
12/3/10 20:4812/1/10GILDGilead Sciences IncDEHealthBioPrdBiological Products, (No DiagAlton Gregg HCAOEVP,CorpS.d-24237.2333-7-1633D-14-19914-4-302-1-1-29106
11/3/10 14:3911/1/10GILDGilead Sciences IncDEHealthBioPrdBiological Products, (No DiagAlton Gregg HCAOEVP,CorpM.d41215.27332737834D-12-5015121031-1-5-7-222
11/3/10 14:3911/1/10GILDGilead Sciences IncDEHealthBioPrdBiological Products, (No DiagAlton Gregg HCAOEVP,CorpS.d-1,12340.1033-28-4534D-12-5015121031-1-5-7-222
10/22/10 18:0010/20/10GILDGilead Sciences IncDEHealthBioPrdBiological Products, (No DiagAlton Gregg HCAOEVP,CorpM.d2315.27332435D-15-14-6171498412-3-205
10/22/10 18:0010/20/10GILDGilead Sciences IncDEHealthBioPrdBiological Products, (No DiagAlton Gregg HCAOEVP,CorpS.d-5939.0033-2-435D-15-14-6171498412-3-205
10/18/10 15:3910/14/10GILDGilead Sciences IncDEHealthBioPrdBiological Products, (No DiagAlton Gregg HCAOEVP,CorpM.d815.27331135D-1-19-1815115640411117
10/18/10 15:3910/14/10GILDGilead Sciences IncDEHealthBioPrdBiological Products, (No DiagAlton Gregg HCAOEVP,CorpS.d-1937.0033-1-135D-1-19-1815115640411117
10/5/10 19:2910/1/10GILDGilead Sciences IncDEHealthBioPrdBiological Products, (No DiagAlton Gregg HCAOEVP,CorpM.d7615.273351735D-21-21-22282-1-1-11122195
10/5/10 19:2910/1/10GILDGilead Sciences IncDEHealthBioPrdBiological Products, (No DiagAlton Gregg HCAOEVP,CorpS.d-21535.7633-6-1535D-21-21-22282-1-1-11122195
5/5/10 14:265/3/10GILDGilead Sciences IncDEHealthBioPrdBiological Products, (No DiagAlton Gregg HCAOEVP,CorpM.d7615.273351636D-28-14-9-21-19-16-8-542-7-1148
5/5/10 14:265/3/10GILDGilead Sciences IncDEHealthBioPrdBiological Products, (No DiagAlton Gregg HCAOEVP,CorpS.d-20040.0033-5-1236D-28-14-9-21-19-16-8-542-7-1148
4/23/10 12:134/21/10GILDGilead Sciences IncDEHealthBioPrdBiological Products, (No DiagAlton Gregg HCAOEVP,CorpM.d19015.8533125036D-20-12-12-11-14-11-12-1130-10-17-50
4/5/10 16:164/1/10GILDGilead Sciences IncDEHealthBioPrdBiological Products, (No DiagAlton Gregg HCAOEVP,CorpM.d7615.273352624D-121-24-7-4-4-1-10-13-26-22-7
4/5/10 16:164/1/10GILDGilead Sciences IncDEHealthBioPrdBiological Products, (No DiagAlton Gregg HCAOEVP,CorpS.d-22945.7933-5-1724D-121-24-7-4-4-1-10-13-26-22-7
3/3/10 18:503/1/10GILDGilead Sciences IncDEHealthBioPrdBiological Products, (No DiagAlton Gregg HCAOEVP,CorpM.d8415.273364418D075233-30-10-4-26-32-19
3/3/10 18:503/1/10GILDGilead Sciences IncDEHealthBioPrdBiological Products, (No DiagAlton Gregg HCAOEVP,CorpS.d-26247.6533-6-2318D075233-30-10-4-26-32-19
2/22/10 17:532/18/10GILDGilead Sciences IncDEHealthBioPrdBiological Products, (No DiagAlton Gregg HCAOEVP,CorpM.d4615.273332018D70839154-1-11-22-30-18
2/22/10 17:532/18/10GILDGilead Sciences IncDEHealthBioPrdBiological Products, (No DiagAlton Gregg HCAOEVP,CorpS.d-14749.0033-3-1418D70839154-1-11-22-30-18
2/3/10 17:462/1/10GILDGilead Sciences IncDEHealthBioPrdBiological Products, (No DiagAlton Gregg HCAOEVP,CorpM.d8415.273364418D6-6-11413852-2-3-1-19-27-19
2/3/10 17:462/1/10GILDGilead Sciences IncDEHealthBioPrdBiological Products, (No DiagAlton Gregg HCAOEVP,CorpS.d-26448.0233-6-2318D6-6-11413852-2-3-1-19-27-19
1/29/10 19:171/27/10GILDGilead Sciences IncDEHealthBioPrdBiological Products, (No DiagAlton Gregg HCAOEVP,CorpM.d815.27331318D10-6-5105634-1-4-2-17-31-20
1/29/10 19:171/27/10GILDGilead Sciences IncDEHealthBioPrdBiological Products, (No DiagAlton Gregg HCAOEVP,CorpS.d-2447.0033-1-318D10-6-5105634-1-4-2-17-31-20
1/6/10 17:371/4/10GILDGilead Sciences IncDEHealthBioPrdBiological Products, (No DiagAlton Gregg HCAOEVP,CorpM.d7615.273353818D-6-15-4-4-7-81-10042-23-18
1/6/10 17:371/4/10GILDGilead Sciences IncDEHealthBioPrdBiological Products, (No DiagAlton Gregg HCAOEVP,CorpS.d-21743.3333-5-2218D-6-15-4-4-7-81-10042-23-18
12/3/09 15:5212/1/09GILDGilead Sciences IncDEHealthBioPrdBiological Products, (No DiagAlton Gregg HCAOEVP,CorpM.d14017.503388018D16433-100-1-1-72-25-19
12/3/09 15:5212/1/09GILDGilead Sciences IncDEHealthBioPrdBiological Products, (No DiagAlton Gregg HCAOEVP,CorpS.d-36645.7533-8-3118D16433-100-1-1-72-25-19
11/9/09 20:0011/5/09GILDGilead Sciences IncDEHealthBioPrdBiological Products, (No DiagAlton Gregg HCAOEVP,CorpM.d5812.683353418D4441-2-19601-1-1-16-17
11/9/09 20:0011/5/09GILDGilead Sciences IncDEHealthBioPrdBiological Products, (No DiagAlton Gregg HCAOEVP,CorpS.d-22545.0033-5-2218D4441-2-19601-1-1-16-17
11/4/09 17:2011/2/09GILDGilead Sciences IncDEHealthBioPrdBiological Products, (No DiagAlton Gregg HCAOEVP,CorpM.d278.943331918D-7-7-1-6-5-5024756-11-9
11/4/09 17:2011/2/09GILDGilead Sciences IncDEHealthBioPrdBiological Products, (No DiagAlton Gregg HCAOEVP,CorpS.d-12842.8233-3-1418D-7-7-1-6-5-5024756-11-9
10/5/09 18:5610/1/09GILDGilead Sciences IncDEHealthBioPrdBiological Products, (No DiagAlton Gregg HCAOEVP,CorpM.d278.943331918D80-5-3-3-4-3-421-5-41-22
10/5/09 18:5610/1/09GILDGilead Sciences IncDEHealthBioPrdBiological Products, (No DiagAlton Gregg HCAOEVP,CorpS.d-37046.2033-8-3018D80-5-3-3-4-3-421-5-41-22
9/3/09 18:529/1/09GILDGilead Sciences IncDEHealthBioPrdBiological Products, (No DiagAlton Gregg HCAOEVP,CorpM.d278.943331523D22-1231-60-2012-225-27
9/3/09 18:529/1/09GILDGilead Sciences IncDEHealthBioPrdBiological Products, (No DiagAlton Gregg HCAOEVP,CorpS.d-36044.9633-8-2523D22-1231-60-2012-225-27
8/5/09 19:318/3/09GILDGilead Sciences IncDEHealthBioPrdBiological Products, (No DiagAlton Gregg HCAOEVP,CorpM.d278.943331228D30-11-9734-1-4-3-2-3-91-24
8/5/09 19:318/3/09GILDGilead Sciences IncDEHealthBioPrdBiological Products, (No DiagAlton Gregg HCAOEVP,CorpS.d-39248.9933-8-2228D30-11-9734-1-4-3-2-3-91-24
7/6/09 19:297/1/09GILDGilead Sciences IncDEHealthBioPrdBiological Products, (No DiagAlton Gregg HCAOSVP,SecrM.d278.943331033D18-11-10382-2-3-1-38-1-5-24
7/6/09 19:297/1/09GILDGilead Sciences IncDEHealthBioPrdBiological Products, (No DiagAlton Gregg HCAOSVP,SecrS.d-37747.0933-8-2033D18-11-10382-2-3-1-38-1-5-24
6/5/09 17:016/3/09GILDGilead Sciences IncDEHealthBioPrdBiological Products, (No DiagAlton Gregg HCAOSVP,GCS-22545.0033-5-1238D8-2023-22650-1324-22
6/3/09 16:106/1/09GILDGilead Sciences IncDEHealthBioPrdBiological Products, (No DiagAlton Gregg HCAOSVP,GCM.d278.94333843D4-21-4-4-1-31300513-20
6/3/09 16:106/1/09GILDGilead Sciences IncDEHealthBioPrdBiological Products, (No DiagAlton Gregg HCAOSVP,GCS.d-12943.1533-3-743D4-21-4-4-1-31300513-20
5/4/09 17:445/1/09GILDGilead Sciences IncDEHealthBioPrdBiological Products, (No DiagAlton Gregg HCAOSVP,GCM.d278.94333843D7-15-2-121-6-3-6-1-2-49-4-11
5/4/09 17:445/1/09GILDGilead Sciences IncDEHealthBioPrdBiological Products, (No DiagAlton Gregg HCAOSVP,GCS.d-36845.9533-8-1643D7-15-2-121-6-3-6-1-2-49-4-11



DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing



S - SaleSale of securities on an exchange or to another person

S - Sale+OESale of securities on an exchange or to another person (after option exercise)

F - TaxPayment of exercise price or tax liability using portion of securities received from the company

P - PurchasePurchase of securities on an exchange or from another person


Return to top
Contact
Copyright © 2017 OpenInsider.com. All rights reserved.




 












Gregg H. Alton, Gilead Sciences, Inc. EVP, Corporate & Medical Affairs - REDBOOKS








































Brands, Marketers, Agencies. Search Less. Sell More.





/   SIGN IN

GET A FREE TRIAL   
CONTACT US: (800) 908-5395





















Gregg H. Alton
EVP, Corporate & Medical Affairs, Gilead Sciences, Inc.

EMAIL: 
                      







              Real-time sales trigger feed - generated by REDBOOKS machine learning and natural language processing technology, tracking 800,000+ news sources to aggregate all new executives, job/role changes and news on decision makers, brands and agencies in the media/marketing industry.
              

              This sales feed is for Gregg H. Alton at Gilead Sciences, Inc.. Gregg H. Alton works as EVP, Corporate & Medical Affairs .  Gilead Sciences, Inc. is a leader in Pharmaceuticals & Health Care Products .
              REDBOOKS tracks personnel changes for advertisers spending over $1 million annually.
              

              For more  leads or media/marketing prospecting automation, start a free trial now.
              

Recent Related News


07/19/2017:


Gilead Sciences, Inc. (NASDAQ:GILD) Stock Traded Well Above Its 50 Day Moving Average

It is currently trading at $71.69 which is just over the 50 day moving average which is $67.84 and barely above the 200 day moving average of $68.56. The 50 day moving average was up $3.85 and the 200 day average went up $3.13 or +4.56%. 5,974K shares changed hands on Wednesday. Overall, volume was down 12.95% under the stocks normal daily volume.
There has been some selling insider activity on Gilead Sciences, Inc. (NASDAQ:GILD) recently. Gregg H. Alton, EVP Comm&Acs ALA, Corp&Med Aff sold $355,300 worth of shares at an average price of $71.06 on July 3rd. .....

People In This Article:
Gregg H. Alton
,                                            John C. Martin
 

07/15/2017:


Gilead Sciences, Inc. (NASDAQ:GILD) Expected to Announce Quarterly Sales of $6.35 Billion

Posted by Joanna Charbonneau on Jul 15th, 2017 // No Comments
Brokerages expect that Gilead Sciences, Inc. (NASDAQ:GILD) will post sales of $6.35 billion for the current quarter, Zacks reports. Five analysts have made estimates for Gilead Sciences’ earnings, with estimates ranging from $6.22 billion to $6.48 billion. Gilead Sciences reported sales of $7.78 billion in the same quarter last year, which would suggest a negative year over year growth rate of 18.4%. The business is expected to report its next quarterly earnings results after the market closes on Wednesday, July 26th.
.....

People In This Article:
Gregg H. Alton
 






Learn more about Gregg H. Alton  and 260,000+ key contacts

  Create targeted lead lists

  Gain insider knowledge with advanced machine  learning
  Real-time verified contact info



Enter Work Email:

Please enter email address.
 Please enter valid email address.









             Learn more about Gregg H. Alton and 260,000+ key contacts
            



























First Name *

 Please enter first name.




Last Name *

 Please enter last name.






Company Name *

 Please enter company name.






Email *





Phone *

 Please enter phone number.
 Please enter 10 digits number.





What industry are you in? *  
                (Please select one the categories below)
Please enter value for the industry.




                     Media Sales
                  




                     Production
                  




                     Ad-Tech/Mar-Tech
                  




                     Sponsorship Sales
                  



  Agency New Business
                  



  Other:
                  




What is your role? *
                 
                 (Please select one the categories below)
Please enter value for the role.



  C-Suite
                  



  VP/Manager
                  



  Sales Rep
                  



  Other:
                  














Thank you for registering for a Free REDBOOKS.com Trial!
We are processing your request and will be in touch shortly to get you started!
For Immediate Assistance, please call us at (800) 908-5395 or email us at info@redbooks.com


























Home
Learn More
FREE Trial


Features




AD THINK Events
Thought Leadership Events
Top Advertiser Directory
Top Agency Directory



Add Your Agency
Update Your Agency
Agency Showcase
Advertising Associations
Creative Spotlight
Services and Suppliers


About Us
Blog
Contact Us
Jobs
Terms & Conditions
Privacy Policy





Customer Support
(800) 908-5395
Connect with us




















Copyright © 2017 Red Books LLC. All rights reserved
































Gregg H Alton - Atherton, CA | Intelius



























Sign In



We found Gregg H Alton in Atherton, CA


Gregg H Alton

                                                                           Intelius found that Gregg H Alton  is  a male between 50 and 60 years old from Atherton, CA.  We have connected them to
                16 addresses,
                13 phones,
                and 10 relatives or associates.
         





Also Known As

Gregg Huber Alton
Gregg Loewy Alton


Get Report Now

Age

Gregg H Alton is in his 50s

Gregg Has Lived In

Atherton, CA
Menlo Park, CA
Palo Alto, CA

Gregg's Relatives

Caroline Loewy
Julie Alton
Haley Alton
Jing Alton







Gregg H Alton



Zodiac SignPisces



GenderMale



Professional Status
Senior Vice President at Gilead Sciences , Inc.



Get Report Now










Want to know more about Gregg? Get a comprehensive background report, find full phone numbers, and other contact information when available, all from billions of available public records.
            Continue below for more details about Gregg, or use our people search engine to find others.
Get Background Check on Gregg H Alton
Get a Criminal Check on Gregg H Alton
Get a Public Record Report on Gregg H Alton
Get a People Search Report on Gregg H Alton


Gregg H Alton's Contact Information
Known Cities Lived In
Find out where Gregg H Alton has lived as well as Gregg H Alton's phone numbers and email addresses.




Gregg H Alton Has Lived in 2 States
California Address for Gregg H Alton


234 P******* A** 

Atherton, CA


Has Lived In

Atherton, CA
Menlo Park, CA


Get Full Address Report










Phone Numbers Associated with Gregg H Alton

(650) ***-**** - Atherton, CA 
(650) ***-**** - San Francisco, CA 
(650) ***-**** - San Mateo, CA 


Get Full Phone Report



Email Addresses Associated with Gregg H Alton

g********n@***.com
a*****h@***.com
g***********n@***.com


Get Email Report




Gregg H Alton's Education Information
Known Schools Attended
Learn about Gregg H Alton's academic history.  Find out which schools Gregg H Alton attended, the dates attended as well as the degrees Gregg H Alton received.
            The following data is not guaranteed for accuracy and should not be used for employment, insurance, credit eligibility, or for any other purpose covered under the Fair Credit Reporting Act.


Gregg H Alton Has Attended 4 Schools
Stanford University Law School 1990 – 1993                              
University of California, Berkeley               1986 – 1989               Gregg H Alton has a Bs in Legal Studies               
University of California, Berkeley               1986 – 1989               Gregg H Alton has a Bs, in Legal Studies               
University of California, Berkeley               1986 – 1989               Gregg H Alton has a Bs, Legal Studies in Legal Studies               


Gregg H Alton's Professional Information
Information regarding Gregg H Alton's professional history.  Find out previous places Gregg H Alton has worked as well as dates employed.
            The following data is not guaranteed for accuracy and should not be used for employment, insurance, credit eligibility, or for any other purpose covered under the Fair Credit Reporting Act.


Gregg H Alton Has Worked at 20 Places
Company: Gilead Sciences , Inc.
               Title: Senior Vice President
Company: Gilead Sciences , Inc.
               Title: Vice President
Gregg H Alton's Experience
Title: Senior Vice President
               Company: Gilead Sciences , Inc.
Job Details
               Company Size: $1 bil and above - Employee Range: 5,000 to less than 25,000
Title: Vice President
               Company: Gilead Sciences , Inc.
Job Details
               Company Size: $1 bil and above - Employee Range: 5,000 to less than 25,000
Additional Professional Information on Gregg H Alton

 See Gregg H Alton's LinkedIn Profile



Gregg H Alton's Social Network and Potential Email Matches
Find out potential social network profiles and potential email usernamed for Gregg H Alton


Gregg H Alton's known Social Networks And Potential Email Matches

Find all of Gregg H Alton's Social Network Profiles

Get Full Report

Search Social Networks
Including Facebook, LinkedIn, MySpace, Google, Twitter, Yahoo, Jigsaw, ZoomInfo and more



Potential Email Matches
Gregg Alton
Username Matches

                  GreggAlton
                  AltonGregg
                  Gregg.Alton
                  Alton.Gregg
                  Gregg_Alton
                  Alton_Gregg
                  Gregg-Alton
                  Alton-Gregg
                  GAlton
               


Popular Email Services

@gmail.com
@aol.com
@yahoo.com
@comcast.net
@hotmail.com
@msn.com
@rocketmail.com
@att.net
@sbcglobal.net
@ymail.com
@facebook.com
@mail.com
@bellsouth.net
@live.com
@earthlink.net
@cox.net
@prodigy.net
@me.com
@peoplepc.com
@juno.com
@rediffmail.com
@mindspring.com
@comcast.com
@charter.net
@outlook.com




All trademarks, product names, company names or logos on this page are the property of their respective owners.
Related People Searches
G Alton







         Intelius is a leading provider of public data about people and their connections to others. Intelius does not provide consumer reports and is not a consumer reporting agency as defined by the Fair Credit Reporting Act (FCRA). This site should not be used to determine an individual’s eligibility for credit, insurance, employment, housing or any other purpose covered by the FCRA. For employment or tenant screening services, please visit our partner Talentwise.
      

About Us
Site Map
About Our Reports
Blog
Help
Contact Us

© 2003 – 2017 PeopleConnect, Inc. d/b/a Intelius. All Rights Reserved.
         Privacy Policy - UPDATED
Terms of Service - UPDATED






What is the FCRA?
The Fair Credit Reporting Act ("FCRA") is a federal law that promotes the accuracy, fairness and privacy of information in the files of consumer reporting agencies.
Intelius does not provide consumer reports and is not a consumer reporting agency as defined by the FCRA. Intelius reports cannot be used for background checks related to consumer credit, insurance, employment, housing or any other purpose
                  prohibited under the FCRA.
You may not use any information obtained from Intelius for any purpose covered by the FCRA.
Find out more about the FCRA here.


















Gregg H. Alton of Gilead Sciences Inc Executive Profile

















 












Welcome!















Company News
Company Site
Premium
Log In


 



















Membership
Home
Portfolio
Stocks
Bonds
Funds
ETFs
CEF
Markets
Tools
Real Life Finance
Discuss





Investing Ideas


Fund Analyst Picks
Picks by Category
Fund Pick Performance
Picks & Pans E-Newsletter
Fund Spy Column
Fund Spy Book
Bond Squad
Fund Video Reports
FundInvestor Newsletter
ETF Investing
Fund Family Experts



Fund Reports


All Fund Analyst Reports
Fund Stewardship Reports



Fund Ratings


Highest-Rated Value
Highest-Rated Growth
Highest-Rated Large-Cap
Highest-Rated Mid-Cap
Highest-Rated Small-Cap
Foreign Fund Standouts
Star Rating Performance
Rating Methodology



Fund Performance


Top 1-Month Performers
Top YTD Performers
Top 1-Year Performers
Top 3-Year Performers
Top 5-Year Performers
Fund Category Returns
Biggest Daily NAV Changes
Closed-End Funds
Exchange-Traded Funds
Quarterly Market Outlook



Fund Screeners


Basic Screeners
Fund Screener
Long-Term Winners
Solid Small-Growth Funds
Conservative Bond Funds

Premium Screeners
Premium Fund Screener
Index Funds
Hidden Gems
Lower-Risk Foreign Funds


Video Center
 
 

 



 



Gilead Sciences Inc
 GILD


Add to PortfolioGet E-mail AlertsPrint This PagePDF ReportData QuestionQuoteChartStock AnalysisPerformanceKey RatiosFinancialsValuationInsidersOwnershipFilingsBondsOverviewExecutive CompensationInsider ActivityKey ExecutivesBoard of DirectorsCommittees
 


Key Executives
                > Gregg H. Alton
            
Gregg H. Alton, Executive Vice President, Commercial and Access ALA, Corporate and Medical Affairs



Profile
Connections






Biography



    Gregg H. Alton, age 49, is our Executive Vice President, Corporate and Medical Affairs. Mr. Alton joined us in 1999, and served as General Counsel from 2000 to 2009, when he was appointed to his current position. In his current role, Mr. Alton is responsible for legal affairs, government affairs, medical affairs, public affairs and emerging market activities. Prior to joining Gilead, Mr. Alton was an attorney at the law firm of Cooley Godward, LLP, where he specialized in mergers and acquisitions, corporate partnerships and corporate finance transactions for healthcare and information technology companies. Mr. Alton is a member of the boards of the AIDS Institute, BayBio, a San Francisco Bay Area life sciences industry organization, the Boys and Girls Clubs of Oakland and Celladon Corporation. He is also a member of the U.S. Government's Industry Trade Advisory Committee on Intellectual Property Rights, the advisory board of UCSF Global Health Sciences and the Dean's Advisory Council at Stanford Law School. Mr. Alton received a bachelor's degree in legal studies from the University of California at Berkeley, and holds a JD from Stanford University.
    





Board Membership




Gregg H. Alton is not a member of any boards




 


  







We value your feedback. Let us know what you think.













 


Site Directory
Site Map
Our Products












 



 



 




Corrections
Help
Advertising Opportunities
Licensing Opportunities
Glossary
RSS
Mobile Portfolio
Affiliate
Careers 
 


International Sites:
        	Australia
Canada
China
France
Germany
Hong Kong
Italy
The Netherlands
Norway
Spain
U.K.
Switzerland

 




Stocks by:
            Name
|
Ticker
|
Star Rating
|
Market Cap
|
Stock Type
|
Sector
|
Industry



Mutual Funds by:
            Star Rating
|
Investment Style
|
Total Assets
|
Category
|
Top Holdings
|
Top Sectors
|
Symbol / Ticker
|
Name



ETFs by:
            Star Rating
|
Category
|
Total Assets
|
Symbol / Ticker
|
Name



Articles by:
            Title
|
Date
|
Author
|
Collection
|
Interest
|
Popularity



Investment Categories by:
            Topic
|
Sector
|
Key Indicators
|
User Interest
|
Market Cap
|
Industry



Premium Stocks by:
            Name
|
Ticker
|
Star Rating
|
Market Cap
|
Stock Type
|
Sector
|
Industry



Premium Mutual Funds by:
            Star Rating
|
Investment Style
|
Total Assets
|
Category
|
Top Holdings
|
Top Sectors
|
Symbol / Ticker
|
Name



Premium ETFs by:
            Star Rating
|
Category
|
Total Assets
|
Symbol / Ticker
|
Name



Popular Articles by:
            Title
|
Date
|
Author
|
Collection
|
Interest
|
Popularity



Popular Investment Categories by:
            Topic
|
Sector
|
Key Indicators
|
User Interest
|
Market Cap
|
Industry




Independent. Insightful. Trusted. Morningstar provides stock market analysis; equity, mutual fund, and ETF research, ratings, and picks; portfolio tools; and option, hedge fund, IRA, 401k, and 529 plan research. Our reliable data and analysis can help both experienced enthusiasts and newcomers.
        © Copyright  Morningstar, Inc. All rights reserved. Please read our Terms of Useand Privacy Policy.Dow Jones Industrial Average, S&P 500, Nasdaq, and Morningstar Index (Market Barometer) quotes are real-time. Russell 2000 quote is 10 minutes delayed.
 


 
















Insider Trading - Alton Gregg H - Form 4 SEC Filings












Home |
Archives |
Products |
About |
Contact |
FAQ |



New User?
Sign Up | 
Sign In









Form 4 Filings


Insider Buys


Significant Buys


Penny StocksInsider Buying


Insider Sales




Insider Buy Sell Ratios


Stock Options


Insider TradingStock Screener


Insider TradingGraph View


Insider Watch





Sec Filings Insider Trading - Alton Gregg H





Select Time period: 
1 Month
2 Months
3 Months
6 Months
1 Year
2 Years
3 Years
4 Years
All Data
 

     



google

   



yahoo!



Send this page to:  

Blog
  



Digg

  



Reddit

  



Facebook

  



Stumble

  



del.icio.us








Enter Stock Ticker Symbol or Cik:




Cik Lookup...






Search By Company or Insider Name:







"Insiders might sell their shares for any number of reasons, but they buy them for only one:
they think the price will rise"
- Peter Lynch ==>>

What is insider trading>>



Email a friend >>...







Historical filings delayed by 6 months. New user?
Sign Up for real time data.
Existing user?
Sign In

Common stock purchase or sale:



TransactionDate
ReportedDate
Company
Symbol
InsiderRelationship
SharesTraded
AveragePrice
TotalAmount
SharesOwned
Filing




2016-11-09Sale
2016-11-141:03 pm
Gilead Sciences Inc
GILD
Alton Gregg HEVP Comm&Acs ALA, Corp&Med Aff
10,000
$79
$790,000
122,964(Direct)
View


2016-09-22Sale
2016-09-264:54 pm
Gilead Sciences Inc
GILD
Alton Gregg HEVP Comm&Acs ALA, Corp&Med Aff
5,000
$81.84
$409,220
132,964(Direct)
View


2016-04-19Sale
2016-04-211:28 pm
Gilead Sciences Inc
GILD
Alton Gregg HEVP, Corp & Med  Affairs
40,000
$100
$4,000,574
177,964(Direct)
View


2016-04-01Sale
2016-04-057:45 pm
Gilead Sciences Inc
GILD
Alton Gregg HEVP, Corp & Med  Affairs
5,000
$91.23
$456,157
142,090(Direct)
View


2016-03-14Sale
2016-03-157:31 pm
Gilead Sciences Inc
GILD
Alton Gregg HEVP, Corp & Med  Affairs
5,000
$90
$450,000
147,090(Direct)
View


2015-12-01Sale
2015-12-031:57 pm
Gilead Sciences Inc
GILD
Alton Gregg HEVP, Corp & Med  Affairs
12,000
$106
$1,272,159
141,422(Direct)
View


2015-11-02Sale
2015-11-042:41 pm
Gilead Sciences Inc
GILD
Alton Gregg HEVP, Corp & Med  Affairs
12,000
$109.4
$1,312,507
143,422(Direct)
View


2015-10-26Sale
2015-10-273:54 pm
Gilead Sciences Inc
GILD
Alton Gregg HEVP, Corp & Med  Affairs
5,000
$110
$550,000
138,422(Direct)
View


2015-10-05Sale
2015-10-071:22 pm
Gilead Sciences Inc
GILD
Alton Gregg HEVP, Corp & Med  Affairs
5,000
$100
$500,000
138,422(Direct)
View


2015-10-01Sale
2015-10-052:13 pm
Gilead Sciences Inc
GILD
Alton Gregg HEVP, Corp & Med  Affairs
7,000
$97.28
$680,930
140,422(Direct)
View


2015-09-15Sale
2015-09-173:55 pm
Gilead Sciences Inc
GILD
Alton Gregg HEVP, Corp & Med Affairs
5,000
$110
$550,000
143,742(Direct)
View


2015-09-01Sale
2015-09-033:06 pm
Gilead Sciences Inc
GILD
Alton Gregg HEVP, Corp & Med  Affairs
12,000
$102.8
$1,233,008
148,742(Direct)
View


2015-08-03Sale
2015-08-045:08 pm
Gilead Sciences Inc
GILD
Alton Gregg HEVP, Corp & Med  Affairs
17,000
$119.1
$2,024,870
154,422(Direct)
View


2015-07-01Sale
2015-07-064:01 pm
Gilead Sciences Inc
GILD
Alton Gregg HEVP, Corp & Med  Affairs
17,000
$116.7
$1,984,446
156,422(Direct)
View


2015-06-01Sale
2015-06-036:07 pm
Gilead Sciences Inc
GILD
Alton Gregg HEVP, Corp & Med  Affairs
17,000
$113.6
$1,931,891
158,422(Direct)
View


2015-05-15Sale
2015-05-197:25 pm
Gilead Sciences Inc
GILD
Alton Gregg HEVP, Corp & Med  Affairs
25,000
$110
$2,750,210
168,422(Direct)
View


2015-05-01Sale
2015-05-057:38 pm
Gilead Sciences Inc
GILD
Alton Gregg HEVP, Corp & Med  Affairs
12,000
$104.1
$1,248,871
155,422(Direct)
View


2015-04-08Sale
2015-04-094:40 pm
Gilead Sciences Inc
GILD
Alton Gregg HEVP, Corp & Med  Affairs
5,000
$100
$500,000
150,422(Direct)
View


2015-04-01Sale
2015-04-035:24 pm
Gilead Sciences Inc
GILD
Alton Gregg HEVP, Corp & Med  Affairs
7,000
$96.53
$675,715
152,422(Direct)
View


2015-03-02Sale
2015-03-047:49 pm
Gilead Sciences Inc
GILD
Alton Gregg HEVP, Corp & Med  Affairs
12,000
$103.6
$1,243,615
159,422(Direct)
View


2015-02-02Sale
2015-02-048:51 pm
Gilead Sciences Inc
GILD
Alton Gregg HEVP, Corp & Med  Affairs
12,000
$105.7
$1,268,719
123,694(Direct)
View




Stock options: Exercise, Award, Grant, Conversion



TransactionDate
ReportedDate
ExercisableExpiration
Company
Symnbol
InsiderRelationship
SharesTraded
ConversionPrice
SharesOwned
Filing




2016-04-19Exercise
2016-04-211:28 pm
N/AN/A
Gilead Sciences Inc
GILD
Alton Gregg HEVP, Corp & Med  Affairs
35,874
$26.99
177,964(Direct)
View


2016-04-19Exercise
2016-04-211:28 pm
N/A2018-07-30
Gilead Sciences Inc
GILD
Alton Gregg HEVP, Corp & Med  Affairs
35,874
$26.99
177,964(Direct)
View


2016-02-16Option Award
2016-02-187:51 pm
N/AN/A
Gilead Sciences Inc
GILD
Alton Gregg HEVP, Corp & Med  Affairs
248
$76.02
184,876(Direct)
View


2016-02-16Option Award
2016-02-187:51 pm
N/AN/A
Gilead Sciences Inc
GILD
Alton Gregg HEVP, Corp & Med  Affairs
12,592
$0
184,876(Direct)
View


2016-02-16Option Award
2016-02-187:51 pm
N/AN/A
Gilead Sciences Inc
GILD
Alton Gregg HEVP, Corp & Med  Affairs
42,614
$0
184,876(Direct)
View


2016-02-16Tax Withholding
2016-02-187:51 pm
N/AN/A
Gilead Sciences Inc
GILD
Alton Gregg HEVP, Corp & Med  Affairs
32,786
$91.15
184,876(Direct)
View


2016-02-01Option Award
2016-02-035:40 pm
N/A2026-02-01
Gilead Sciences Inc
GILD
Alton Gregg HEVP, Corp & Med  Affairs
75,030
$84.05
75,030(Direct)
View


2015-12-01Exercise
2015-12-031:57 pm
N/AN/A
Gilead Sciences Inc
GILD
Alton Gregg HEVP, Corp & Med  Affairs
10,000
$24.3
141,422(Direct)
View


2015-12-01Exercise
2015-12-031:57 pm
N/A2022-01-26
Gilead Sciences Inc
GILD
Alton Gregg HEVP, Corp & Med  Affairs
10,000
$24.3
141,422(Direct)
View


2015-11-02Exercise
2015-11-042:41 pm
N/AN/A
Gilead Sciences Inc
GILD
Alton Gregg HEVP, Corp & Med  Affairs
10,000
$24.3
143,422(Direct)
View


2015-11-02Exercise
2015-11-042:41 pm
N/A2022-01-26
Gilead Sciences Inc
GILD
Alton Gregg HEVP, Corp & Med  Affairs
10,000
$24.3
143,422(Direct)
View


2015-10-26Exercise
2015-10-273:54 pm
N/AN/A
Gilead Sciences Inc
GILD
Alton Gregg HEVP, Corp & Med  Affairs
5,000
$24.3
138,422(Direct)
View


2015-10-26Exercise
2015-10-273:54 pm
N/A2022-01-26
Gilead Sciences Inc
GILD
Alton Gregg HEVP, Corp & Med  Affairs
5,000
$24.3
138,422(Direct)
View


2015-10-05Exercise
2015-10-071:22 pm
N/AN/A
Gilead Sciences Inc
GILD
Alton Gregg HEVP, Corp & Med  Affairs
5,000
$24.3
138,422(Direct)
View


2015-10-05Exercise
2015-10-071:22 pm
N/A2022-01-26
Gilead Sciences Inc
GILD
Alton Gregg HEVP, Corp & Med  Affairs
5,000
$24.3
138,422(Direct)
View


2015-10-01Exercise
2015-10-052:13 pm
N/AN/A
Gilead Sciences Inc
GILD
Alton Gregg HEVP, Corp & Med  Affairs
5,000
$24.3
140,422(Direct)
View


2015-10-01Exercise
2015-10-052:13 pm
N/A2022-01-26
Gilead Sciences Inc
GILD
Alton Gregg HEVP, Corp & Med  Affairs
5,000
$24.3
140,422(Direct)
View


2015-09-15Exercise
2015-09-173:55 pm
N/AN/A
Gilead Sciences Inc
GILD
Alton Gregg HEVP, Corp & Med Affairs
5,000
$24.3
143,742(Direct)
View


2015-09-15Exercise
2015-09-173:55 pm
N/A2022-01-26
Gilead Sciences Inc
GILD
Alton Gregg HEVP, Corp & Med Affairs
5,000
$24.3
143,742(Direct)
View


2015-09-01Exercise
2015-09-033:06 pm
N/AN/A
Gilead Sciences Inc
GILD
Alton Gregg HEVP, Corp & Med  Affairs
8,625
$24.3
148,742(Direct)
View


2015-09-01Exercise
2015-09-033:06 pm
N/AN/A
Gilead Sciences Inc
GILD
Alton Gregg HEVP, Corp & Med  Affairs
1,375
$23.75
148,742(Direct)
View


2015-09-01Exercise
2015-09-033:06 pm
N/A2020-01-28
Gilead Sciences Inc
GILD
Alton Gregg HEVP, Corp & Med  Affairs
1,375
$23.75
148,742(Direct)
View


2015-09-01Exercise
2015-09-033:06 pm
N/A2022-01-26
Gilead Sciences Inc
GILD
Alton Gregg HEVP, Corp & Med  Affairs
8,625
$24.3
148,742(Direct)
View


2015-08-03Exercise
2015-08-045:08 pm
N/AN/A
Gilead Sciences Inc
GILD
Alton Gregg HEVP, Corp & Med  Affairs
15,000
$23.75
154,422(Direct)
View


2015-08-03Exercise
2015-08-045:08 pm
N/A2020-01-28
Gilead Sciences Inc
GILD
Alton Gregg HEVP, Corp & Med  Affairs
15,000
$23.75
154,422(Direct)
View


2015-07-01Exercise
2015-07-064:01 pm
N/AN/A
Gilead Sciences Inc
GILD
Alton Gregg HEVP, Corp & Med  Affairs
15,000
$23.75
156,422(Direct)
View


2015-07-01Exercise
2015-07-064:01 pm
N/A2020-01-28
Gilead Sciences Inc
GILD
Alton Gregg HEVP, Corp & Med  Affairs
15,000
$23.75
156,422(Direct)
View


2015-06-04Option Award
2015-06-056:24 pm
2015-07-042025-06-03
Celladon Corp
CLDN
Alton Gregg HDirector
10,000
$2.16
40,000(Direct)
View


2015-06-01Exercise
2015-06-036:07 pm
N/AN/A
Gilead Sciences Inc
GILD
Alton Gregg HEVP, Corp & Med  Affairs
4,375
$23.6
158,422(Direct)
View


2015-06-01Exercise
2015-06-036:07 pm
N/AN/A
Gilead Sciences Inc
GILD
Alton Gregg HEVP, Corp & Med  Affairs
10,625
$23.75
158,422(Direct)
View


2015-06-01Exercise
2015-06-036:07 pm
N/A2019-01-21
Gilead Sciences Inc
GILD
Alton Gregg HEVP, Corp & Med  Affairs
4,375
$23.6
158,422(Direct)
View


2015-06-01Exercise
2015-06-036:07 pm
N/A2020-01-28
Gilead Sciences Inc
GILD
Alton Gregg HEVP, Corp & Med  Affairs
10,625
$23.75
158,422(Direct)
View


2015-05-15Exercise
2015-05-197:25 pm
N/AN/A
Gilead Sciences Inc
GILD
Alton Gregg HEVP, Corp & Med  Affairs
24,375
$19.08
168,422(Direct)
View


2015-05-15Exercise
2015-05-197:25 pm
N/AN/A
Gilead Sciences Inc
GILD
Alton Gregg HEVP, Corp & Med  Affairs
625
$23.6
168,422(Direct)
View


2015-05-15Exercise
2015-05-197:25 pm
N/A2021-01-20
Gilead Sciences Inc
GILD
Alton Gregg HEVP, Corp & Med  Affairs
24,375
$19.08
168,422(Direct)
View


2015-05-15Exercise
2015-05-197:25 pm
N/A2019-01-21
Gilead Sciences Inc
GILD
Alton Gregg HEVP, Corp & Med  Affairs
625
$23.6
168,422(Direct)
View


2015-05-01Exercise
2015-05-057:38 pm
N/AN/A
Gilead Sciences Inc
GILD
Alton Gregg HEVP, Corp & Med  Affairs
10,000
$19.08
155,422(Direct)
View


2015-05-01Exercise
2015-05-057:38 pm
N/A2021-01-20
Gilead Sciences Inc
GILD
Alton Gregg HEVP, Corp & Med  Affairs
10,000
$19.08
155,422(Direct)
View


2015-04-08Exercise
2015-04-094:40 pm
N/AN/A
Gilead Sciences Inc
GILD
Alton Gregg HEVP, Corp & Med  Affairs
5,000
$19.08
150,422(Direct)
View


2015-04-08Exercise
2015-04-094:40 pm
N/A2021-01-20
Gilead Sciences Inc
GILD
Alton Gregg HEVP, Corp & Med  Affairs
5,000
$19.08
150,422(Direct)
View


2015-04-01Exercise
2015-04-035:24 pm
N/AN/A
Gilead Sciences Inc
GILD
Alton Gregg HEVP, Corp & Med  Affairs
5,000
$19.08
152,422(Direct)
View


2015-04-01Exercise
2015-04-035:24 pm
N/A2021-01-20
Gilead Sciences Inc
GILD
Alton Gregg HEVP, Corp & Med  Affairs
5,000
$19.08
152,422(Direct)
View


2015-03-02Exercise
2015-03-047:49 pm
N/AN/A
Gilead Sciences Inc
GILD
Alton Gregg HEVP, Corp & Med  Affairs
10,000
$19.08
159,422(Direct)
View


2015-03-02Exercise
2015-03-047:49 pm
N/A2021-01-20
Gilead Sciences Inc
GILD
Alton Gregg HEVP, Corp & Med  Affairs
10,000
$19.08
159,422(Direct)
View


2015-02-13Option Award
2015-02-196:31 pm
N/AN/A
Gilead Sciences Inc
GILD
Alton Gregg HEVP, Corp & Med  Affairs
248
$85.61
216,216(Direct)
View


2015-02-13Option Award
2015-02-196:31 pm
N/AN/A
Gilead Sciences Inc
GILD
Alton Gregg HEVP, Corp & Med  Affairs
18,940
$0
216,216(Direct)
View


2015-02-13Option Award
2015-02-196:31 pm
N/AN/A
Gilead Sciences Inc
GILD
Alton Gregg HEVP, Corp & Med  Affairs
85,334
$0
216,216(Direct)
View


2015-02-13Tax Withholding
2015-02-196:31 pm
N/AN/A
Gilead Sciences Inc
GILD
Alton Gregg HEVP, Corp & Med  Affairs
66,794
$103.8
216,216(Direct)
View


2015-02-02Exercise
2015-02-048:51 pm
N/AN/A
Gilead Sciences Inc
GILD
Alton Gregg HEVP, Corp & Med  Affairs
10,000
$19.08
123,694(Direct)
View


2015-02-02Exercise
2015-02-048:51 pm
N/A2021-01-20
Gilead Sciences Inc
GILD
Alton Gregg HEVP, Corp & Med  Affairs
10,000
$19.08
123,694(Direct)
View


2015-02-01Option Award
2015-02-039:50 pm
N/A2025-02-01
Gilead Sciences Inc
GILD
Alton Gregg HEVP, Corp & Med  Affairs
51,690
$104.8
51,690(Direct)
View









    © 2005-2017 SecForm4.Com All rights reserved.
    Archives:
    2017 2016 2015 2014 2013 2012 ... 
    Mon, 24 Jul 2017 20:55:37 -0500
  

    SEC is the U.S. Securities and Exchange Commission. EDGAR is a trademark of the SEC.
    SecForm4.Com is not affiliated with or approved by the U.S. Securities and Exchange Commission (SEC).
Terms of Use |
    Privacy Statement |
  




















	ABOUT









































































ABOUTWORKFOR YOUMEDIATRENDING POLICYEVENTSSUPPORT







Directors & Staff|Faculty|Advisory Board|Fellows|Opportunities|Support Us|Contact Us





 

 
 














                        Leonard D. Schaeffer



                        Drew E. Altman, Ph.D.



                        Gregg H. Alton



                        David Beier, J.D.



                        Robert Bradway, M.B.A.



                        C. Duane Dauner



                        Lloyd H. Dean



                        John D. Diekman, Ph.D.



                        Joaquin Duato, M.B.A.



                        Joel Freedman



                        Mark B. Ganz



                        Dennis Gillings, Ph.D., CBE



                        Gavin S. Herbert, Sr.



                        Thomas R. lnsel, M.D.



                        Pamela D. Kehaly



                        Jack H. Knott, Ph. D.



                        Robert Kocher, M.D.



                        Leigh Anne Leas



                        Robert Margolis, M.D.



                        Steve Miller, MD



                        Michael A. Mussallem



                        Vassilios Papadopoulos, DPharm, PhD, DSc (hon)



                        Norman C. Payson, M.D.



                        Tom Pike



                        Thomas M. Priselac, M.P.H.



                        Robert D. Reischauer, Ph.D.



                        Mike L. Ryan, Pharm.D.



                        Judith A. Salerno, M.D., M.S.



                        Sue Siegel



                        Faye Wattleton



                        Timothy Wright, M.D.








 





















Gregg H. Alton


Executive Vice President, Corporate and Medical Affairs
Gilead
Gregg Alton joined Gilead
Sciences in 1999. From 2000 to 2009 he served as General Counsel. In his
current role, Mr. Alton is responsible for legal affairs, government affairs, medical
affairs, public affairs and emerging market activities. Prior to joining
Gilead, Mr. Alton was an attorney at the law firm of Cooley Godward, LLP, where
he specialized in mergers and acquisitions, corporate partnerships and
corporate finance transactions for healthcare and information technology
companies. 

Mr. Alton is a member of the
boards of the AIDS Institute, BayBio (a San Francisco Bay Area life sciences
industry organization), the Boys and Girls Clubs of Oakland and Celladon
Corporation. He is also a member of the U.S. Government's Industry Trade
Advisory Committee on Intellectual Property Rights, the advisory board of UCSF
Global Health Sciences and the Dean’s Advisory Council at Stanford Law School.
Mr. Alton received a bachelor's degree in legal studies from the University of
California at Berkeley, and holds a JD from Stanford University.






 











































SHARE








select

LinkedInGoogleBookmarksDeliciousRedditMySpaceTumblrTell a friend




























			{1}				
			



##LOC[OK]##







			    {1}				
			    





##LOC[OK]##
##LOC[Cancel]##





			{1}				
			

##LOC[OK]##
##LOC[Cancel]##









